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Summary 
The RNA polymerase II (Pol II) is known to play a central role in transcribing all protein 
coding genes and non-coding RNAs (ncRNAs) in eukaryotic cells. Intriguingly, the 
majority of short ncRNAs are immediately degraded in the nucleus and therefore referred 
to as cryptic unstable transcripts (CUTs). Studies in S. cerevisiae have revealed that the 
Nab3-Nrd1-Sen1 (NNS) complex couples the short ncRNA transcription termination and 
RNA degradation by the nuclear exosome. Sen1 (252 kDa) is a well-conserved 5'→3' 
RNA helicase and a key player in transcription termination. 
In order to understand better the mechanism of termination, the helicase core domain of 
Sen1 (94 kDa) was expressed, purified and crystallized, and the crystal structure was 
solved. As shown in this work, Sen1 helicase domain has a very similar overall structure to 
that of Upf1-like helicases.  Surprisingly, the structure reveals a unique feature, the “brace”, 
which fastens the accessory subdomains to RecA1 and frames the helicase in a favorable 
conformation for RNA binding. Moreover, structure based biochemical studies reveal that 
the “prong” is an essential element for 5'→3' unwinding and releasing the transcription 
complex from the template. Finally, I discuss the mechanism of RNA helicase 
translocation in the 5'→3' direction and propose a structure based model for Pol II 
elongation complex dissociation. 
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Zusammenfassung 
Die RNA Polymerase II (Pol II) spielt bekanntermaßen eine zentrale Rolle in der 
Transkription aller proteinkodierenden Gene und nicht-kodierender RNAs (ncRNAs, von 
English: non-coding RNAs) in Eukaryoten. Interessanterweise wird ein Großteil der 
kleinen ncRNAs noch im Zellkern umgehend abgebaut und deshalb als kryptische 
instabile Tranksripte (CUTs, von English: cryptic unstable transcripts) bezeichnet. Studien 
in S. cerevisiae haben gezeigt, dass der Nab3-Nrd1-Sen1 (NNS) Komplex die 
Transkriptionstermination kleiner ncRNAs mit dem exosomalen RNA Abbau im Zellkern 
verbindet. Sen1 (252 kDa) ist eine hochkonservierte 5'→3' RNA-Helikase und nimmt 
eine Schlüsselrolle in der Transkriptionstermination ein. 
Um den Terminationsmechanismus besser zu verstehen wurde die zentrale 
Helikasedomäne von Sen1 (94 kDa) exprimiert, aufgereinigt und kristallisiert, sowie deren 
Kristallstruktur gelöst. Wie in dieser Arbeit beschrieben, besitzt Sen1 eine 
Helikasedomäne mit einer ähnlichen Gesamtstruktur wie Upf1-artige Helikasen. 
Überraschenderweise weist die Struktur als einzigartiges Merkmal den sogenannten „brace“ 
(Deutsch: Klammer) auf, der die zusätzlichen Unterdomänen an RecA1 fixiert und die 
Helikase in einer günstigen Konformation für die RNA-Bindung hält. Desweiteren zeigen 
strukturbasierte biochemische Analysen, dass der sogenannte „prong“ (Deutsch: Zinke) 
eine wichtige Komponente für die 5'→3' Entwindung und die Freisetzung des 
Transkriptionskomplexes vom Matrizenstrang ist. Abschließend wird der Mechanismus 
der RNA-Helikasetranslokation in 5'→3' Richtung diskutiert und ein Modell für die 
Dissoziation des Pol II Elongationskomplexes vorgeschlagen, basierend auf den 
Proteinstrukturen. 
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ncRNA non-coding RNA 
NLS  nuclear localization sequence 
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Nrd1  nuclear pre-mRNA down-regulation protein 1 
nt  nucleotide 
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
PDB  Protein Data Bank 
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PSI  Paul Scherrer Institute 
Pol II  RNA polymerase II 
PROMPT promoter upstream transcript 
PVDF  polyvinylidene fluoride 
r.m.s.d  root mean square deviation 
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S. pombe Schizosaccharamyces pombe 
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SAD  single-wavelength anomalous diffraction 
SDS  sodium dodecyl sulphate 
Sen1  splicing endonuclease gene 1 
SETX  senataxin 
SF  superfamily 
snRNA small nuclear RNA 
snRNP small nuclear ribonucleo proteins 
snoRNA small nucleolar RNA 
ss  single stranded 
TBE  Tris base, boric acid and EDTA containing buffer 
TFIIH  transcription factor II H 
Tm  melting temperature 
TRAMP Trf4-Air2-Mtr4 polyadenylation 
tRNA  transfer RNA 
Trx  thioredoxin tag 
UTR  untranslated region 
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1 Introduction 
Transcription is the first decoding step towards functional expression of the genomic 
information in the cell. About 85% of the Saccharomyces cerevisiae genome is transcribed 
(David et al, 2006) and the RNA polymerase II (Pol II) plays a central role in transcribing 
all protein coding genes as well as many non-coding RNAs (ncRNAs), such as cryptic 
unstable transcripts (CUTs), small nuclear RNAs (snRNAs), and small nucleolar RNAs 
(snoRNAs). In fact, the eukaryotic genome is pervasively transcribed to a large extent 
because Pol II binds DNA within the nucleosome-free regions and forms two adjacent 
preinitiation complexes, resulting in bidirectional transcription of coding and antisense 
strands of DNA  (reviewed in Berretta & Morillon, 2009). Transcription is essential for a 
flow of life, however it is equally essential to terminate transcription in order to maintain a 
balance of RNA concentrations within a cell. Therefore, eukaryotic cells have developed 
several mechanisms which restrict the extent of pervasive transcription, e.g. by limiting 
transcription initiation of ncRNAs via gene looping or chromatin remodeling (Terzi et al, 
2011; Tan-Wong et al, 2012; Whitehouse et al, 2007). But the main transcriptome 
surveillance mechanism mostly relies on early termination of unwanted transcription and 
immediate degradation of transcripts (reviewed in Jensen et al, 2013).  
 
1.1 Two main Pol II transcription termination pathways in S.cerevisiae 
Eukaryotic cells maintain tight control over every transcription step through a large 
number of specific factors that bind to the C-terminal domain (CTD) of Rpb1, the largest 
subunit of the Pol II core complex. The CTD contains a conserved heptapetide Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (YSPTSPS, repeated 26 times in yeast and 52 times in 
humans) and is differentially phosphorylated at Tyr1, Ser2, Ser5, and Ser7 throughout the 
transcription cycle. In S. cerevisiae, the mechanism of initiation of all transcripts by Pol II 
appears to be similar, but, dependent on the phosphorylation pattern of the CTD and the 
sequence of new transcripts, two distinct pathways, the canonical and the NNS-dependent 
pathways, are utilized for transcription termination (Figure 1-1).  
When Pol II binds to a promoter, the CTD is dephosphorylated. Once Pol II has escaped 
from the promoter, the CTD is phosphorylated on Ser5 by transcription factor TFIIH, 
resulting in a conformational change of the CTD (Komarnitsky et al, 2000; Buratowski, 
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2009; Kim et al, 2009; Heidemann et al, 2013). In S. cerevisiae, this modification is 
recognized by the Nab3-Nrd1-Sen1 (NNS) complex (Kubicek et al, 2012; Vasiljeva et al, 
2008), which then binds to Pol II and scans the emerging nascent RNA for specific 
sequence motifs to terminate the transcription at early elongation (Wlotzka et al, 2011; 
Mischo & Proudfoot, 2013; Grzechnik et al, 2015). If these motifs are not detected, Pol II 
continues to transcribe RNA and the conformation of the CTD is altered by a decrease of 
Ser5 and increase of Tyr1 and Ser2 phosphorylation levels, which in turn leads to the 
dissociation of the NNS complex. Phosphorylation level of Tyr1 and Ser2 increases over 
the gene length, but Tyr1 phosphorylation level sharply decreases at the 3'-end of the gene 
enabling binding of the cleavage and polyadenylation CPF-CF complex to the CTD for 
canonical termination of Pol II transcription (Grzechnik et al, 2015; Heidemann et al, 
2013; Mayer et al, 2012).  
Notably, there is no clear, pronounced separation between the two termination pathways 
but rather a gradual decrease in efficiency with an overlap that might function as a 
termination fail-safe mechanism (Gudipati et al, 2008; Grzechnik et al, 2015; Rondón et 
al, 2009). The efficiency of early termination can be modulated in response to 
environmental changes (e.g. nutrient availability), suggesting that ncRNA termination 
could work in concert with regulatory mechanisms like the Ras pathway (Darby et al, 
2012). Moreover, for certain genes transcription termination may occur by both pathways 
alternatively and the choice of the pathway is autoregulated by a stem-loop near the polyA 
site in the 3'-UTR, or by certain RNA-binding proteins that might cover premature 
termination sequence motifs (Gudipati et al, 2012a; Kim & Levin, 2011). Thus, the NNS 
complex can function in transcriptional attenuation (Kim & Levin, 2011; Chen et al, 
2017a).  
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Figure 1-1. Two major pathways of RNA polymerase II transcription termination. 
Phosphorylation levels of the CTD of Pol II throughout the transcription cycle coordinate the 
recruitment of transcription factors and termination complexes. The Nab3-Nrd1-Sen1 (NNS) 
complex terminates transcription of short ncRNA and promotes degradation of CUTs or 
processing of sn/snoRNA by the nuclear exosome, whereas the canonical transcription termination 
of Pol II by the cleavage and polyadenylation CPF-CF complex leads to mRNA export to the 
cytoplasm. Both complexes bind to the transcription machinery and scan the emerging nascent 
RNA for conserved termination motifs; however, the NNS complex is recruited much earlier and 
binds transcript within a few hundreds nucleotides after transcription start site whereas in the 
CPF-CF pathway the complex is recruited at 3'-UTR of the RNA. This timing advantage allows 
the NNS complex to detect and control pervasive transcription early during elongation in order to 
control pervasive transcription. Modified from Porrua & Libri, 2015b. 
 
Termination factors involved in the two pathways bind to the CTD of all Pol II complexes 
regardless of the template DNA (Heo et al, 2013; Lenstra et al, 2013), indicating that the 
termination pathway is determined by the distance of the Pol II from the transcription 
start site (i.e., the phosphorylation ratio of Ser5 to Ser2), rather than the template 
sequence. Thus, short ncRNAs are terminated by the NNS pathway within 1kb 
downstream of the transcription start site, whereas mRNAs are terminated via the CPF-
CF pathway (Richard & Manley, 2009; Kuehner et al, 2011; Marquardt et al, 2011).  
Generally, the termination pathway determines the fate of transcripts. In the CPF-CF 
pathway, the nascent mRNAs are cleaved and polyadenylated at the 3'-end and the stable 
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mature transcripts are then exported to the cytoplasm (reviewed in Mischo & Proudfoot 
2013). In the NNS pathway, the transcripts are linked to the nuclear RNA exosome for 
rapid degradation of CUTs or processing of sn/snoRNA (reviewed in Porrua & Libri, 
2015b). Therefore, the NNS complex has a pivotal role in transcriptome surveillance by 
selective termination and degradation of cryptic transcripts (Jensen et al. 2013). 
It is important to note that the NNS pathway is not evolutionary conserved. Nrd1 and 
Nab3 are yeast-specific proteins, however, even within various yeast species the function of 
Nrd1 and Nab3 orthologs differ. For example, in S. pombe, Nrd1 ortholog Seb1 is involved 
in canonical mRNA transcription termination rather than forming a typical NNS-like 
complex (Lemay et al, 2016). By contrast, human transcription termination-coupled decay 
of ncRNAs (PROMPTs) requires the nuclear cap binding complex and the nuclear 
exosome targeting complex NEXT (Andersen et al, 2013). 
 
1.2 The NNS complex recruitment for transcription termination 
The current transcription termination model postulates that the NNS complex is recruited 
first to CTD of Pol II and in the presence of termination signal – to the nascent RNA. 
Nrd1 and Nab3 contain RNA-recognition motif (RRM) domains (Figure 1-2) (Hobor et 
al, 2011; Franco-Echevarría et al, 2017) with sequence specificity for consensus binding 
sites GUAA/G and UCUU(G), respectively (Wlotzka et al, 2011; Mischo & Proudfoot, 
2013; Carroll et al, 2004; 2007). Importantly, these sequence motifs occur at high 
frequencies in antisense direction but are depleted in sense direction of protein coding 
regions, thus distinguishing ncRNAs from protein coding mRNAs (Cakiroglu et al, 2016). 
In vitro data suggests that Nrd1 and Nab3 form a heterodimer to have a cooperative 
binding to RNA (Carroll et al, 2004; Creamer et al, 2011; Porrua et al, 2012).  
Upon Nrd1-Nab3 binding, Sen1 is brought to the nascent RNA via direct interaction with 
Nab3 (Chinchilla et al, 2012; Porrua & Libri, 2015b), however the mechanism of Sen1 
recruitment is not understood. In vitro studies show that Sen1 alone is sufficient for 
termination of a stalled polymerase (Porrua & Libri, 2013; Han et al, 2017). It has also 
been shown that Sen1 can bind to the CTD phosphorylated at Ser2 (i.e. during productive 
elongation) independently of Nrd1-Nab3 (Chinchilla et al, 2012). Thus, it is possible that 
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Nrd1-Nab3 is needed to increase transcription termination efficiency rather than Sen1 
recruitment alone. Supporting this possibility is the finding that Nrd1-Nab3 dimer binds 
to both the extending RNA and Pol II and contributes to polymerase pausing 
(Schaughency et al, 2014). 
 
 
Figure 1-2. The Nrd1-Nab3-Sen1 (NNS) complex. 
(a) Schematic presentation of the domain composition of S. cerevisiae proteins. Nrd1 contains a 
CTD-interacting domain (CID) that binds to CTD phosphorylated at Ser5. Nrd1 also contains 
two RNA-recognizing motif (RRM) domains that are fused together. Nab3 harbors only one 
RRM domain and forms a heterodimer with Nrd1 to bind RNA cooperatively. Sen1 binds RNA 
in a sequence independent manner; however, it can be recruited to RNA via interaction with Nab3 
or CTD phosphorylated at Ser2. The bars indicate the regions of Sen1 interaction with other 
proteins. Sen1 contains a nuclear localization sequence (NLS). (b) RRM domain structures. Nrd1 
is bound UUAGUAAUCC (PDB: 2LO6) and Nab3 is bound UCUU (PDB: 2L41). 
 
 
Interestingly, Nrd1 and Nab3 have an unusual sequence stretch of 8 and 16 glutamines, 
respectively, at the C-termini and therefore Nrd1-Nab3 heterodimers can polymerize onto 
nascent RNA to assemble a large ribonucleoprotein complex (Carroll et al, 2007; Loya et 
al, 2013a; 2013b). Moreover, Sen1 also has a stretch of polar residues at the N-terminus. 
All together, this hints to a possibility of all three proteins forming nuclear foci that may 
enhance the control of pervasive transcription at highly expressed Pol II genes (Loya et al, 
2013b; Bacikova et al, 2014; O'Rourke et al, 2015). 
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1.3 The NNS complex links short ncRNA to TRAMP and the nuclear 
exosome 
Contrary to the CPF-CF pathway, termination by the NNS-mediated termination is 
coupled to degradation of CUTs or trimming of the precursors of sn(o)RNAs by the 
nuclear exosome (Kubicek et al, 2012). Transcriptomic studies of yeast strains with a 
catalytically inactivated nuclear exosome have revealed up to 1600 CUTs that are otherwise 
immediately degraded and not detectable in wild type cells (Wyers et al, 2005; Xu et al, 
2009; Gudipati et al, 2008; 2012b). 
It has been suggested that the NNS complex links transcription with nuclear RNA 
surveillance after Nrd1 was shown to associate with Rrp6, the catalytic subunit of the 
nuclear exosome (Vasiljeva & Buratowski, 2006). Follow-up studies have revealed that the 
CID of Nrd1, the domain that contributes to the NNS complex recruitment to the early 
elongating Pol II, is also required for direct interaction with Trf4 subunit of the TRAMP 
complex (Tudek et al, 2014) or another nuclear exosome cofactor Mpp6 (Kim et al, 2016). 
Structural studies have confirmed that CID interaction with CTD and Trf4 (Figure 1-3) is 
mutually exclusive (Kubicek et al, 2012). Thus, Nrd1 can interact with the nuclear exosome 
cofactors TRAMP and Mpp6 or directly with the nuclear exosome, however this direct 
interaction is possible only when Nrd1 is not bound to Pol II.  
 
 
Figure 1-3. Nrd1 CID domain binding to phosphorylated CTD and Trf4. 
Structure of Nrd1CID bound with CTD (green) phosphorylated at Ser5 (orange) is shown in the left 
panel (PDB: 2LO6). Structure of Nrd1CID bound with Nrd1-interacting motif (NIM) of Trf4, a 
subunit of TRAMP is shown in the right panel (PDB: 2MOW). Nrd1 interaction with CTD and 
Trf4 is mutually exclusive. 
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The nuclear exosome is a barrel-shape complex, which has two catalytic subunits, Rrp44 
and Rrp6, associated at the bottom and on the top of the barrel, respectively. RNA can be 
either threaded through the central channel to reach Rrp44 or trimmed by Rrp6 on the top 
of the complex. Both enzymes are 3'→5' exonucleases, however, Rrp44 possesses an 
additional endonuclease activity (reviewed in Butler & Mitchell, 2011; Kilchert et al, 
2016). According to the current model, the nuclear exosome can be in a “closed” (bound 
Rrp6 only) or “open” (bound Rrp6 and cofactor Mtr4/Mpp6) conformation (Makino et al, 
2015; Schuch et al, 2014). The exosome is active in both conformations, however the 
conformational change determines whether the RNA will pass through the central channel 
of the exosome for degradation by Rrp44 or whether it will be trimmed at the surface of 
the exosome. Exo- and endonuclease activities of the exosome are coordinate by TRAMP 
and Mpp6 cofactors (Makino et al, 2015). In addition, fate of the RNA is largely 
dependent on its secondary structure (single-stranded vs. bulky RNA).  
Interestingly, Nrd1 also can influence the choice between degradation and 3'-end 
trimming of ncRNA (Vasiljeva & Buratowski, 2006), most likely because of mutually 
exclusive interactions with Rrp6, TRAMP and Mpp6 and multiple ways by which the 
NNS complex binds to the exosome (Kim et al, 2016). Moreover, Nab3 can also interact 
with Rrp6 and enhance its catalytic activity independently of Nrd1 (Fasken et al, 2015). 
No direct interaction of Sen1 and exosome or its cofactors has been detected yet, thus the 
main function of Sen1 is most likely limited to transcription machinery dissociation.  
Surprisingly, Nrd1-Nab3 is not limited to transcripts of Pol II but has also been shown to 
act in the nuclear surveillance of aberrant transcripts of RNA polymerase III, e.g. pre-
tRNAs and pre-RPR1, by recognizing consensus binding motifs or structural 
abnormalities in the RNA and recruiting TRAMP complex (Wlotzka et al, 2011). 
 
1.4 DNA/RNA helicase classification 
DNA and RNA helicases are essential for every step of nucleic acid metabolism, from 
chromatin remodeling and DNA replication to mRNA transcription and protein 
translation. Depending on their structure and function, helicases are classified into six 
superfamilies (SFs) (reviewed in Singleton et al, 2007). The helicases that form a 
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hexameric ring-shape structure (SF3 to SF6) have been found only in viruses and certain 
bacteria, but not in eukaryotes. In contrast, all eukaryotic DNA/RNA helicases have a core 
composed of two structurally similar domains, RecA1 and RecA2, which resemble the fold 
of the recombination protein RecA. Depending on the characteristic sequence motifs 
within and the accessory subdomains on the surface of RecA domains, the helicases are 
separated to SF1 and SF2 (Pyle, 2008; Fairman-Williams et al, 2010) (Figure 1-4). These 
motifs are either involve in ATP binding and hydrolysis (motifs Q, I, II and VI) or 
mediate DNA/RNA binding (motifs Ia, Ib, Ic, IIIa, IV and IVa). Additionally, the 
accessory subdomains can interact with RecA domains and/or nucleic acid to stabilize the 
helicase binding and therefore influence its catalytic activity. A defined coordination of 
nucleic acid binding and ATP hydrolysis enables the helicase to move along the nucleic 
acid chain, which may result in removal of secondary structure or associated proteins.  In 
yeast, there are only three families of processive helicases that can translocate along RNA. 
 
 
Figure 1-4. Conserved motifs of the RNA helicases in eukaryotes. 
A schematic representation of conserved sequence motifs in the helicase core across eukaryotic 
RNA helicases of SF1 and SF2. Grey rectangles represent two RecA domains; a black line 
indicates a linker between the domains. Motifs Q, I, II, and VI (magenta rectangles) are involved 
to ATP binding and hydrolysis. Motif IIIa is found only in SF1, and together with Ib it 
contributes to adenine ring binding to the cleft, whereas this interaction in SF2 is made by motif 
IVa (magenta rectangles). Motifs Ia, Ic, IV, and V (turquoise rectangles) are involved in RNA 
binding. Motifs III and Va (dark yellow rectangles) coordinate the nucleotide and RNA binding. 
Modified from Jankowsky & Fairman, 2007. 
 
DEAH/RHA family helicases (e.g. Prp43, Sub2, Brr2) and Ski2-like family helicases (e.g. 
Ski2, Mtr4, Suv3) belong to SF2 and can translocate only in the 3'→5' direction. These 
helicases are required for proper splicing, RNA degradation or processing by the exosome. 
Conversely, Upf1-like family helicases (e.g. Upf1 and Sen1) of SF1 translocate in an 
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opposite 5'→3' direction, although they bind the RNA in the same polarity as SF2 
helicases. Upf1-like helicases have a function in nonsense-mediated decay (NMD) or 
transcription termination (Pyle, 2008; Fairman-Williams et al, 2010).  
 
1.5 RNA helicase Sen1 in S. cerevisiae 
Sen1 is the key enzyme in facilitating the termination of ncRNAs (Chinchilla et al, 2012); 
however, the helicase has a broader function beyond pervasive transcription control. 
Initially, Sen1 was identified as a splicing endonuclease gene 1 (SEN1) in a screen for 
mutations that inhibit pre-tRNA splicing (DeMarini et al, 1992). It was later discovered 
that mutations in SEN1 result in a broad range of phenotypes, including disruption of 
nucleolar organization, defects in transcription, transcription-coupled DNA repair, RNA 
processing, and snRNP assembly (Ursic et al, 1995; Ursic, 1997; Steinmetz et al, 2006). 
Sen1 also binds to the transcription machinery to resolve DNA:RNA hybrid (R-loops) and 
protects the genome from R-loop mediated genome damage, particularly in higher 
eukaryotes (Mischo et al, 2011; Hamperl & Cimprich, 2014). Finally, it has been 
suggested that Sen1 binds to replicating forks as well to counteract the DNA:RNA hybrid 
formation at collision sites between transcription and replication machineries, thus, 
preventing DNA damage checkpoint activation (Alzu et al, 2012). 
Interestingly, Sen1 is a low-abundance nuclear protein (125 copies/cell) (Ghaemmaghami 
et al, 2003; Ursic et al, 1995) in comparison to roughly 14,000 transcribing Pol II in the 
cell (Borggrefe et al, 2001), 19,000 and 5,800 molecules of Nrd1 and Nab3, respectively 
(Ghaemmaghami et al, 2003). Overexpression of SEN1 does not lead to a significant 
increase of Sen1 concentration and the excess amount of the protein appears to be 
degraded by the ubiquitin-dependent 26S proteosome (DeMarini et al, 1995). Also, Sen1 
is a low-processivity enzyme that disengages the RNA soon after its binding (Han et al, 
2017). Together, this helps avoid spurious termination.  
The broad spectrum of Sen1 functions is made possible by multiple protein-protein 
interactions (Ursic et al, 2004; Singh et al, 2015). For example, the N-terminal domain of 
Sen1 interacts with Pol II, the endonuclease Rad2 (required for nucleotide excision repair), 
and the RNase III endonuclease Rnt1 (involved in RNA processing) (Ursic et al, 2004; 
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Chinchilla et al, 2012; Li et al, 2016). Mutations that disrupt these interactions cause 
defects in transcription termination, transcription-coupled DNA repair and RNA 
processing. Furthermore, the C-terminal domain of Sen1 is required for interactions with 
Nab3 and phosphatase Glc7 (a subunit of CPF factor) (Jamonnak et al, 2011; Nedea et al, 
2008; Ursic et al, 2004).  
 
 
Figure 1-5. Comparison of domain organization in yeast Sen1 and human SETX. 
Schematic presentation of a full-length S. cerevisae Sen1 and its human ortholog SETX. The 
numbers indicate the residue numbers. The bars indicate the regions of helicase interaction with 
other proteins. Both Sen1 and SETX contain a nuclear localization sequence (NLS) (shown in 
green boxes). The shortest known viable fragment of Sen1 comprises residues 1089-1929. SETX is 
not essential in human. 
 
 
 
Surprisingly, the N- and C-terminal domains are dispensable for viability unless both are 
deleted at the same time (DeMarini et al, 1992; Chen et al, 2014; 2017b; Steinmetz et al, 
2006). Moreover, Sen1 mutant strains that have abolished interaction with Pol II or Nab3 
show an increase of certain yet different ncRNAs as a result of termination readthrough 
(Jenks et al, 2008; Chen et al, 2017b; Schaughency et al, 2014). This phenotype implies the 
presence of at least two alternative pathways for these transcripts. Since Sen1 can 
associated with Pol II, either by directly binding to Ser2-phosphorylated CTD (with the 
N-terminus) or through indirect interactions with the Ser5-phosphorylated CTD as part 
of the NNS complex (with the C-terminus) (Jamonnak et al, 2011; Chinchilla et al, 2012), 
it is possible that the deletion of one of the flanking domains is compensated by another 
domain. Nevertheless, Sen1 does not require the interaction neither with the CTD of Pol 
II nor Nab3 for termination reaction itself but rather for earlier steps of commitment to 
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termination, the helicase alone is sufficient to dissociate the paused polymerase in vitro 
(Porrua & Libri, 2013). However, Sen1 must be recruited to the RNA in close proximity 
to the transcription machinery and the polymerase should be relatively slow or stalled 
(Hazelbaker et al, 2013; Han et al, 2017). 
Sen1 (252.5 kDa) is a DNA/RNA-dependent ATPase that translocates in the 5'→3' 
direction and is capable of unwinding RNA:DNA duplexes (Martin-Tumasz & Brow, 
2015; Han et al, 2017; Kim et al, 1999; Hamperl & Cimprich, 2014). To date, the shortest 
known region (1089-1929) of Sen1 that is essential for yeast viability comprises a 
characteristic SF1 helicase core and a flanking region containing a nucleus localization 
signal (Chen et al, 2014)(Figure 1-5).  
The human ortholog, Senataxin (SETX), has also been implicated to have similar 
functions to that of yeast Sen1. Additionally, SETX is required for the efficient 
transcription termination of protein-coding RNA, and is involved in regulation of the 
circadian rhythm and microRNA biogenesis (Bennett et al, 2013; Skourti-Stathaki et al, 
2011). However, SETX seems to be non-essential in mammals; loss-of-function of the 
helicase leads to downregulation of mitochondrial biogenesis and oxidative stress (Bennett 
et al, 2013; Sariki et al, 2016). Over 40 missense mutations at the N-terminus and helicase 
core have been reported to cause progressive neurological diseases, e.g., amyotrophic lateral 
sclerosis (ALS4) or ataxia ocular apraxia type 2 (AOA2) (reviewed in Bennett & La Spada, 
2015). The mechanisms underlying these diseases are not understood, but it is suggested 
that the mutations cause SETX dysfunction either directly through helicase inactivation or 
by disrupting protein–protein interactions. 
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2 Aims 
The ultimate goal of this thesis work is to gain understanding of the mechanism of how 
the helicase Sen1 disrupts the elongation complex of Pol II. An approach combining 
biochemical and structural methods needs to be taken to define the molecular mechanism 
of Sen1 binding to RNA, translocation in 5'→3' direction and RNA:DNA duplex 
unwinding properties. A high-resolution crystal structure of the Sen1 helicase domain and 
its comparison to available structures of other SF1 RNA helicases would help to reveal why 
Sen1 is the only RNA helicase that can terminate the transcription of Pol II. The insights 
and the conclusions of this work should provide strategies for further studies of 
transcription termination. 
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3 Results 
3.1 Characterization of the active helicase core 
3.1.1 Identification of soluble Sen1 constructs 
Prior to the initiation of this project there was no successful recombinant expression of 
Sen1 reported. Also here, expression of full-length Sen1 (1-2231) was not successful either 
in E. coli or in insect cells. Thus, a combination of structure prediction (PSIPRED, 
Phyre2) and sequence alignment (ClustalW2) was applied to design various constructs of 
Sen1 (Figure 3-1) (structure prediction, multiple alignment and a full list of constructs see 
in Appendix). 
 
 
Figure 3-1. Tested constructs of Sen1. 
Initially, a full-length Sen1 and the shorter constructs containing both the N-terminal and the 
helicase domains were tried to express. Also, the domains were expressed separately. The N-
terminal domain expression levels were too low for the crystallization trials or not expressed at all 
and further only expression and purification of the helicase domain alone was continued. 
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The expression of the N-terminal domain was not suitable for crystallization, thus the 
main focus was on obtaining the helicase domain alone. At first, a construct 976-1880 that 
lacks both the N-terminus domain and the low-complexity C-terminus end was designed. 
The fragment was amplified from S. cerevisiae genomic DNA and cloned into a vector with 
a CPD-His8 tag at the C-terminus. The construct was well expressed in E. coli, however, 
during purification it appeared that the protein was about 20 kDa smaller than it was 
expected (Figure 3-2, a). Mass-spectrometry and Edman sequencing confirmed the 
endogenous protein degradation of 130 amino acids at the N-terminus. 
 
 
Figure 3-2. Test-purification of Sen1 helicase domain (SDS-PAGE). 
(a) Sen1 helicase core [976-1880]. Expected molecular weight of the construct with the tag was 
126 kDa but the protein ran just above 100 kDa. (b) Ni2+-NTA elution samples of different Sen1 
helicase core constructs. 
 
Secondary structure prediction (see Appendix 1) suggested that residues 1095-1106 form 
an α-helix, therefore the following constructs starting at residue 1095 were designed. 
Moreover, for some of the constructs the C-terminal region was extended up to the 
nucleus localization signal (NLS) (residue 1910) with the idea to obtain longer fragments 
of the protein and do limited proteolysis. The constructs were designed for the expression 
in E. coli and tested for solubility. Additionally, T4 lysozyme (T4L) and thioredoxin (Trx) 
tags were tested to check whether a tag changes the expression levels of the proteins. It 
appeared that all the constructs were similarly well expressed (Figure 3-2, b). Some of the 
constructs were purified in a large scale and set-up for crystallization. A fragment 1095-
1904 (hereafter referred to as Sen1Hel) yielded to crystals and, therefore, the further studies 
were continued only on it. 
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3.1.2 Purification of the Sen1Hel  
Several rounds of expression tests and purification buffer screens were performed in order 
to determine the conditions for the highest yield of Sen1Hel (see Methods 6.2.2 and 
Methods 6.2.4). The best purity was achieved when Lysis buffer (20 mM sodium 
phosphate pH 8.0, 500 mM NaCl, 2 mM MgCl2, 1 mM β-mercaptoethanol) was 
supplemented with 10 % (v/v) glycerol, 30 mM imidazole, benzonase, and protease 
inhibitors and the CPD-His8 -tag was cleaved ‘on column’ by adding HRV 3C protease to 
Ni2+-affinity beads and incubating at 4°C overnight (see Methods 6.2.4.2). A combination 
of Ni2+-affinity and heparin ion exchange chromatography steps led to almost pure protein 
(Figure 3-3, a). 
 
 
Figure 3-3. Purification of Sen1Hel. 
(a) A chromatogram of the elution from heparin sepharose column with a linear NaCl gradient. 
Red and blue lines correspond to the absorbance at 260 nm and 280 nm, respectively. Brown line is 
the conductivity and green line is percentage of Buffer B. A corresponding SDS-PAGE gel, 
stained with Coomassie blue, shown at the bottom. After elution from heparin sepharose column, 
Sen1Hel was concentrated and loaded onto a Superdex 200 [16/600] gel filtration column. (b) A 
chromatogram of SEC and a corresponding SDS-PAGE gel, stained with Coomassie blue, shown 
at the bottom. Red and blue lines correspond to the absorbance at 260 nm and 280 nm, 
respectively. In the main peak (green dots), the ratio of 260 nm and 280 nm is below 0.5, 
indicating that the sample is not contaminated with nucleic acids. A small fraction of the protein 
eluted in void-volume or as aggregate (first two peaks, violet dots). 
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The collected elution fractions from the heparin column were concentrated to ~12 mg/mL 
and then further purified by size exclusion chromatography (SEC)(Figure 3-3, b). In this 
step the aggregates were separated (void volume and peak 1) and the protein eluted in a 
peak at the expected elution volume for a globular protein of 90 kDa (14 ml on Superdex 
200 [16/600] column). Every purification step was monitored by SDS-PAGE. 
Usually, 3 L of bacterial culture yielded up to 20 mg of purified protein, which could be 
concentrated to 10 mg/mL or higher. In order to avoid aggregates forming upon freezing, 
50 % (w/v) glycerol was added to the buffer. When kept on ice, Sen1Hel was generally very 
stable and could be stored for weeks. 
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3.1.3 Biochemical characterization of Sen1Hel  
To test whether Sen1Hel is a functionally relevant construct, Dr. Zhong Han and Dr. Odil 
Porrua from collaboration group of Dr. Domenico Libri (Institut Jacques Monod, Paris) 
tested the ATPase and helicase activities and did in vitro transcription termination assays 
(Porrua & Libri, 2013). It appeared that the helicase core domain alone has similar 
biochemical properties to those of endogenous full-length Sen1 (the results are discussed 
more in detail  later). In parallel, the collaborators studied the endogenous Sen1 proteins. 
Their helicase domain contains 976-1880 fragment, the same that I could purify from E. 
coli, however, endogenously expressed protein did not degrade. The results showed that, 
indeed, the helicase domain alone is sufficient for transcription termination in vitro and 
that the N- and C-terminal domains are most relevant for processes in vivo (Han et al, 
2017). Very similar conclusions were made by Brow’s group, who studied Sen11095-1876 in 
vitro (Martin-Tumasz & Brow, 2015). Whether Sen1 is regulated through 
posttranscriptional modifications is still not clear, but the fact that the recombinant protein 
retains the capability of endogenous protein suggests that the modifications are not crucial, 
at least for the tested truncations and activities. 
The optimal RNA length and sequence needed to obtain the Sen1Hel-RNA crystal 
structure was determined by using an RNase protection assay and fluorescence anisotropy 
measurements (Figure 3-4).  In the RNase protection assays, Sen1Hel was incubated with a 
32P body-labeled 57-mer RNA in the presence of different nucleotides for 1h on ice. After 
incubation, to the samples RNase A and RNase T1 were added to digest the RNA that 
was not bound by the helicase. The protected RNA fragments were then extracted and 
analyzed by denaturing PAGE, and the gels were visualized by phosphor-imaging (see 
Methods 6.2.14). Sen1Hel covers ~11-nucleotide fragments in the presence of ADP:AlFx or 
ADP:BeFx (Figure 3-4, a). Minor fragments of ~23 nucleotides were likely due the 
contiguous binding of more than one protein to the same RNA. No protection was 
observed when only ADP or AMPPNP was added.  
In fluorescence anisotropy measurements, different Sen1Hel concentrations were incubated 
with a 5’-end fluorescein-labeled 15-mer RNA or ssDNA in a presence of ATP and 
binding affinities were measured as described in Methods 6.2.13. Sen1Hel showed strongest 
binding to ssDNA (KD of 0.25 µM) and polyU15 RNA (KD of 1.11 µM).  
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Figure 3-4. RNA binding by Sen1Hel. 
(a) RNase protection assay in the presence of different nucleotides. RNA fragments were obtained 
by digesting 57-mer RNA. Sen1Hel binds RNA only in a presence of ADP:BeFx or ADP:AlFx but 
not in a presence of ADP or AMPPNP. Sen1Hel protects 11-nucleotide fragments. For 
comparison, the footprints of helicase Dbp5 are shown on the right side of the gel. (b) 
Fluorescence anisotropy measurements. Sen1Hel can bind to both RNA and ssDNA, with the 
higher affinity for the latter.  
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3.2 Crystal structure determination of Sen1Hel 
3.2.1 Sen1Hel crystallization 
Purified Sen1Hel was concentrated to 3-4 mg/mL (30-35 µM), mixed with a 1.2 molar 
excess of polyU15 RNA and a 10-fold molar excess of freshly prepared nucleotides to set up 
for automated crystallization screening in the Crystallization facility of our department. 
The initial crystallization screening was done using several multicomponent screens by 
sitting-drop vapor diffusion method in 96-well plates. Most of crystallization hits were 
observed in crystallization conditions from the in-house Complex screen II solution (Table 
3-1) at 4°C (Figure 3-5, a-d). The crystals were forming clusters of needles (a), plates (b-c) 
or three-dimensional rods (c-d) within 6-10 days. Adjusting precipitant pH and PEG 
concentrations as well as drop size helped to optimize the crystallization conditions further 
(Figure 3-5, e-h). Optimized crystals formed larger rod clusters (e), which could be broken 
apart, or single triangular prisms (f-h), and were mounted to nylon loops for data 
collection. Prior to flash freezing in liquid nitrogen, the crystals were briefly soaked in 
mother liquor supplemented with 25-28 % (w/v) ethylene glycol for cryo-protection. In 
some cases, crystals were soaked in mother liquor additionally supplemented with polyU15 
RNA. 
 
3.2.2 X-ray data collection 
Crystals were first pre-screened using in-house D8 VENTURE (Bruker) X-ray 
diffractometer to select well diffracting (up to 4 Å) and efficiently cryo-protected ones (no 
ice ring observed in diffraction pattern). X-ray data collection of data sets used for structure 
determination was performed at the super-bending magnet beamline X06DA (PXIII) at 
the Swiss Light Source (Villigen, Switzerland). A native data was collected at 1.0 Å 
wavelength and a single-wavelength anomalous diffraction (SAD) data set was collected at 
2.095 Å. 
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Figure 3-5. Crystal shape changes upon optimization of crystallization conditions. 
(a-d) Initial crystals in multicomponent precipitant solution screens. (e-h) Crystals after 
optimization of precipitant solution. The best diffracting crystals (h) were grown at 4 °C by 
hanging-drop vapor diffusion from 2 µL drops formed by equal volumes of protein and of 
crystallization solutions (6 % (w/v) PEG 8000, 8 % (v/v) ethylene glycol, 0.1 M HEPES pH 7.2). 
 
 
The best crystals diffracted to 1.8-2.5 Å and could bear up to 4 MGy dosage (<0.5 MGy 
per 360°) until the first signs of diffraction decay were visible, thus multiple 360° data sets 
could be collected in different orientations on a single crystal. This enabled doing a single-
wavelength anomalous diffraction experiment from intrinsic sulfur atoms of cysteine and 
methionine residues (S-SAD) (see Methods 6.3.2). The weak anomalous signal of intrinsic 
sulfur could be assessed by measuring the individual reflections at different angles, i.e., 
multiple trajectories of reciprocal lattice points. Merging of the data sets increased the 
proportion of anomalous signal while the number of unique reflections remains nearly the 
same. Eventually, 4 x 360° data sets from one crystal were sufficient to increase the 
anomalous signal correlation by 16 % at 3 Å resolution (Table 3-2). The statistics of data 
collection are listed in the Table 3-3. 
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Table 3-2. Statistics of data processing. 
 
 
 
3.2.3 Crystal structure determination and evaluation 
The data could be indexed and processed in orthorhombic space group P21212 with one 
molecule per symmetric unit. The data was processed using XDS and scaled and merged 
with XSCALE (Kabsch, 2010). The high-resolution data cutoff was based on the 
statistical indicators CC1/2 and CC* (Karplus & Diederichs, 2012). Substructure 
determination and phasing were performed with SHELXC/D/E (Sheldrick, 2010) using 
HKL2MAP (Pape & Schneider, 2004). The successful SHELXD substructure solution, in 
a search for 25 sulfur sites, had a CCall and a CCweak of 36.9 and 18.2, respectively. Density 
modification resulted in a clear separation of hands. Three cycles of chain tracing resulted 
in the automatic building of 275 amino acids with SHELXE.  
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The initial model was built automatically using BUCCANEER (Cowtan, 2006) and 
corrected and completed manually using COOT (Emsley & Cowtan, 2004) and the 
experimental electron density map in. Further model refinements were done against native 
data with PHENIX.refine (Adams et al, 2010). When building in ADP:AlFx into the 
model, it appeared that only ADP molecule was bound to Sen1Hel and no electron density 
for the AlFx moiety could be obtained (Figure 3-6). Finally, also ligands (glycerol and 
ethylene glycol) and water molecules were built in into the model. 
The final model was refined at 1.8-Å resolution with an Rfree of 18.4 % and Rfactor of 15.3 % 
and good stereochemistry (Table 3-3). In particular, 98 % of residues are in the most 
favored regions of the Ramachandran plot and the model has no outliers (Figure 3-7, b). 
Based on the wwPDB evaluation tool, which compares all available structures of the same 
resolution, Sen1Hel model has relatively good percentile ranks also for key global quality 
indicators like Clashscore and outliers of Sidechain or Real-space R-value Z-score (RSRZ) 
(Figure 3-7, a). 
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Figure 3-6. Sen1Hel model building 
(a) ADP molecule and magnesium ion are built into the Fo-Fc electron density map (green). (b) A 
hexahydrated octahedral architecture of magnesium dication and six oxygen atoms, four from water 
molecules and two from Thr1364 residue and β-phosphate of ADP. The 2Fo-Fc electron density map 
is contoured at 1.7σ. (c) Magnesium (green sphere) is coordinated at the active site of Sen1 by 
amino acid residues (Thr1364, Asp1590, Glu1591, Glu1418, Arg1422 and Lys1363), ADP and is 
surrounded with six waters. (d) The overall view of final Sen1Hel model (blue). Water molecules 
and ligands are displayed in red and grey, respectively. 
 
 
 
Figure 3-7. Sen1Hel  model validation. 
(a) Overall X-ray structure quality validation with the respect to all structures in the Protein Data 
Bank (http://rcsb.org). (b) Ramachandran plot of Φ and Ψ torsion angles of the α-chain of the 
protein. 
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Table 3-3. Crystallographic data collection and refinement statistics. 
Data set Sen1Hel native Sen1Hel S-SAD 
Data collection 
Space group P 21 21 2 P 21 21 2 
Unit cell (a, b, c in Å) 90.285, 171.944, 69.094 90.2, 171.66, 68.85 
Wavelength (Å) 1.00 2.095 
Resolution range (Å) 48.39 - 1.787 85.83  - 2.145  
  (1.851 - 1.787) (2.221 - 2.144) 
Total reflections 680,302 (29,401) 1,643,000 
Unique reflections 100,766 (2,170) 114,276 (8,032) 
Multiplicity 13.2 (13.5)   
Completeness (%) 98.27 (95.07) 93.9 (68.81) 
Mean I/sigma(I) 28.21 (19.71) 22.47 (1.2) 
Wilson B-factor 29.6 30.57 
R-merge 0.085 (1.500) N/D 
R-meas 0.092 0.086 
CC1/2 0.999 (0.610) 0.999 (0.69) 
CC* 1 (1) 1 (1) 
Refinement 
R-work (%) 15.28   
R-free (%) 18.36   
Number of non-hydrogen atoms 6,970   
    macromolecules 5,543   
    ligands 337   
    water 1,090   
Protein residues 682   
RMS(bonds) 0.011   
RMS(angles) 1.39   
Ramachandran favored (%) 98   
Ramachandran outliers (%) 0   
Clashscore 10.86   
Average B-factor 49.2   
    macromolecules 42   
    ligands 100.50   
    solvent 66.4   
Statistics for the highest-resolution shell are shown in parentheses. 
 
 
3.2.4 Trials to change crystal-packing in order to obtain protein-RNA structure 
One of the project goals was to achieve the structure of Sen1Hel in complex with RNA, 
however in the first attempts no RNA density could be observed. Sen1Hel was again set up 
with 11-nucleotide polyU RNA or polyT ssDNA  and ADP:AlFx or ADP:BeFx for 
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crystallization trials. Additionally, catalytically inactive Sen1Hel (E1591Q) was set up with 
ATP and nucleic acid. Despite extensive trials, including UV-cross linking and crystal 
soaking with RNA, no density for nucleic acid chain in the structure could be obtained. 
Most likely reason for that was the tight crystal packing that was unfavorable for nucleic 
acid binding, as the helicases have different RNA-bound and RNA-free conformations. 
Moreover, one of the crystal-packing contacts (residue Leu1549) seemed to be at the site 
where 3’-end of RNA would reside.  
Therefore, several mutants that might disrupt the packing were cloned, expressed and 
purified as described for Sen1Hel (Methods 6.2.4). Firstly, the disordered region within 1C 
subdomain (residues 1471–1543) was deleted. Secondly, three sites of protein-protein 
interactions in the crystal packing (see Figure 3-8) were mutated: the N-terminus end was 
truncated to residue 1105 (ΔN-term) and two point mutations, L1549D and G1769R, 
were introduced. Thirdly, crystallization trials with uncleaved tags (CPD, Trx or T4 
lysozyme) were set up. Nevertheless, the unit cell parameters in all cases were the same and 
the RNA/DNA density could never be observed. 
 
 
Figure 3-8. Attempts to disrupt protein-protein crystal-packing contacts. 
Sen1Hel has three extensive sites of protein-protein interactions in crystal packing. The topside of 
β-barrel (blue molecule) interacts with the N-terminal end as well as the side of RecA1 domain 
(yellow molecule). The bottom of RecA2 domain of the third molecule (magenta) has a contact to 
the backside of β-barrel (blue) and the side of RecA1 domain (yellow molecule). All together the 
three molecules “wrap” around the 1C subdomain (yellow molecule). In order to disrupt the 
contact sites, a mutation in the 1C subdomain (L1549D and G1769R) as well as a N-terminus 
truncation of 10 amino acids was introduced into new constructs. 
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3.3 The structure of Sen1Hel 
The model of Sen1Hel has only one molecule in the asymmetric unit. The majority of the 
cloned construct could be modeled with exception of a disordered region in the subdomain 
1C (residues 1471–1543), the C-terminus (residues 1876–1904) and a loop region in the 
RecA1 domain (residues 1382–1395). Also, the regions encompassing residues 1705–1713 
and 1799–1801 have very poor electron density and could not be modeled. The model 
includes one ADP and one magnesium ion (Figure 3-9). Overall, Sen1Hel has a domain 
organization similar to that of the related helicases Upf1 (Upf1Hel, also known as Upf1-
ΔCH) (Cheng et al, 2007; Clerici et al, 2009; Chakrabarti et al, 2011)  and IGHMBP2 
(IGHMBP2Hel) (Lim et al, 2012). 
 
   
 
Figure 3-9. Crystal structure of yeast Sen1Hel. 
Top: schematic representation of the domain organization of the SenHel.  Bottom: the front and the 
side views of the SenHel structure. The core domain is formed of two RecA domains (yellow). The 
“prong” (red) and the “stalk” with the “barrel” on top of it are protruding from RecA1.  The “brace” 
is wrapping around the “stalk” and is sandwiched between the “stalk” and the “barrel”.  
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3.3.1 Architecture of Sen1Hel 
3.3.1.1 Two central RecA domains 
The helicase core of Sen1 is composed of two small globular RecA domains (residues 
1314-1651 and 1657-1861) that pack against each other forming a 10 Å-wide wedge-like 
cleft, and are connected with a short linker of five residues. RecA2 is rotated of about 30° 
from the position that is typical of helicases in an active RNA-ATP-bound conformation 
(Figure 3-14) (Pyle, 2008). Both domains have a similar topology of a central parallel β-
sheet surrounded by eight α-helices. The loops between β-strands contain characteristic 
motifs for DNA/RNA and ATP binding (Figure 3-10). Tight coordination of the motif 
binding to nucleotides and RecA domain rotation upon ATP hydrolysis is a key for 
translocation on nucleic acid (Saikrishnan et al, 2009).  
 
 
 
Figure 3-10. Conserved motifs for nucleic acid and ATP binding mapped on Sen1Hel structure. 
The characteristic sequence motifs are involved in ATP binding and hydrolysis (Q, I, Ib, II, IIIa, 
and VI, shown in magenta), in DNA/RNA binding (Ia, Ic, IV, V, and Vb, shown in turquoise) 
and coordination between nucleic acid and ATP binding (III and Va, shown in dark yellow). 
Importantly, Motif IIIa is a part of the linker between two RecA domains and is found only in SF1 
helicases. 
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Figure 3-11. Multiple sequence alignment of Upf1-like helicases 
The multiple sequence alignment was done using Clustal Omega, and the conservation was 
calculated using BLOSUM62 and shown in purple.  
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3.3.1.2 ADP binding  
ADP is bound to the RecA1 domain inside the cleft between RecA1 and RecA2 (Figure 
3-9 and Figure 3-10). The adenine ring is sandwiched between an apolar surface of 
Lys1365 of RecA1 and Tyr1655 of the linker. This tyrosine is conserved among Upf1-like 
helicases, it corresponds to Tyr638Upf1 and Tyr422IGHMBP2 (see alignment Figure 3-11), and 
is a part of the Motif IIIa (Gln-Tyr-Arg-Met), which is present only in SF1 helicases but 
not in SF2 (Fairman-Williams et al, 2010). In SF2 helicases, e.g. in yeast Ski2 (Halbach et 
al, 2012), the adenine ring is also sandwiched between the two RecA domains by Phe328 
and Arg767 (part of Motif IVa that is found only in SF2 helicases), however the linker to 
the nucleotide binding is not involved (Figure 3-13). In addition, the adenine amino group 
is recognized by conserved Gln1339 side chain (corresponding to Gln413Upf1, 
Gln196IMGMBP2 and Gln334Ski2) of the Q-motif. This Gln-based specificity is common to 
all SF1 and SF2 helicases that have substrate preference to ATP over other nucleotides 
(Cordin et al, 2004). Gly1362, Lys1363, Thr1364 and Arg1422 coordinate α- and β-
phosphates of the ADP (Figure 3-13). 
 
Figure 3-12.  Sen1Hel ADP binding plot. 
A two-dimensional representation of the residues involved in ADP binding by Sen1Hel. ADP is 
shown in black, the residues are shown in yellow. The spheres in red represent oxygen, in blue – 
nitrogen, in green – magnesium ion. Blue dashed lines indicate hydrogen bonds, and numbers 
indicate bond length in Å. The adenine ring is sandwiched between an apolar surface of Lys1356 
and an aromatic ring of Tyr1655. The ADP binding plot was calculated using LigPlot. 
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Figure 3-13. Comparison of nucleotide binding by Sen1, Upf1 (SF1) and Ski2 (SF2). 
Residues involved in nucleotide binding are shown as sticks. The RNA helicases belong to 
different superfamilies and yet have many conserved residues. The adenine amino group is 
recognized by Gln1339Sen1/Gln413Upf1/Gln334Ski2 (Q-motif). The α-phosphate of the nucleotide is 
coordinated by Gly1362Sen1/Gly435Upf1/Gly356Ski2 (Motif I) and β-phosphate by Lys1363Sen1/ 
Lys436Upf1/Lys357Ski2 and Thr1634Sen1/Thr437Upf1/Thr358Ski2. At this site in Sen1 and Upf1 
structures is also to see bound magnesium (green sphere). Waters are shown in red spheres. The γ-
phosphate is coordinated by Arg1820Sen1/Arg801Upf1/Arg763Ski2 (Motif VI). When a helicase forms 
a tertiary complex with ATP and RNA, the side chain of Gln1619Sen1/Gln601Upf1 (Motif III) also 
binds to the γ-phosphate. 
  
 
3.3.1.3 Accessory subdomains: the “stalk” and the “barrel” (1B)  
Additionally to two RecA domains, Sen1 also has two subdomains, 1B and 1C, 
characteristic to Upf1-like helicases protruding from the RecA1. Subdomain 1B is the 
160-residue long region of two antiparallel helices that form a so-called “stalk” and a 6-
stranded β-barrel (referred to as the “barrel”). The helices of the “stalk” pack against each 
other and against the side of RecA1 with extensive hydrophobic interactions and are rather 
in a fixed position alike to the “barrel”, which is connected to the “stalk” with short linkers, 
and hovers over RecA1. In comparison to UPF1Hel and IGHMBP2Hel structures, the 
“barrel” of Sen1Hel has more elaborated topology and shorter loop regions. But perhaps 
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more importantly, the “barrel” in apo-structure of Sen1Hel is fixed to the top of the “stalk” 
whereas in the other helicases the “barrel” is positioned on the top of RecA domains where 
the RNA would reside (Figure 3-14). 
 
 
Figure 3-14. Structural comparison of Sen1Hel with related helicases. 
The apo-structures of the helicase core of yeast Sen1, human Upf1 (PDB: 2GJK) and IGHMBP2 
(PDB: 4B3F). The structures are shown in the orientation of superposed RecA1 domains. Dashed 
lines indicate missing parts of the structure. The schematic representations of full-length helicase 
domain organization are shown on top, with structured domains shown as rectangles and 
unstructured regions as a black line. Domains in scheme and the structure are highlighted in the 
same colors. Among Upf1-like helicases only Sen1 has an additional fragment to the helicase core, 
which braces the “barrel” and the “stalk” together, and therefore is referred to as the “brace”.  
 
 
 
3.3.1.4 Accessory subdomains: the “brace” is unique to Sen1 
Structural comparison of Sen1Hel with Upf1Hel and IGHMBP2Hel revealed key differences 
in subdomain 1B. First of all, the “barrel” has a short 3-residue linker to the ascending 
helix of the “stalk” in contrast to a 10-residue linker observed in Upf1Hel or to a helix in 
IGHMBP2Hel. Similarly, the “barrel” is directly connected to the descending helix of the 
“stalk” in Sen1Hel, whereas it has a short linker in case of Upf1Hel and IGHMBP2Hel. Thus, 
in contrast to other Upf1-like helicases, the “barrel” of Sen1 seems to be spatially 
restricted. In addition, Sen1 has a unique N-terminal segment (residues 1096-1149) that 
we refer to as the “brace” (Figure 3-14). The “brace” fastens together the RecA1, the 
“stalk” and the “barrel” with extensive hydrophobic interactions.  
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The “brace” starts with a short helix (α1) that inserts via aliphatic side chains (Leu1109 
and Arg1108) into a hydrophobic surface groove formed between the RecA1 domain 
(Ala1573, Ala1578 and Tyr1606) and the descending helix of the “stalk” (Tyr1303) 
(Figure 3-15). The polypeptide chain then continues with a second helix (α2) sandwiched 
between the “barrel” and both helices of the “stalk”. Here, hydrophobic residues on one 
side (Tyr1117 and Leu1121) are engaged in van der Waals interactions with aliphatic side 
chains of the “barrel” (with Leu1216, Leu1244 and Lys1246). Hydrophobic residues on 
the other side (Leu1116, Ile1120 and Trp1123) make apolar interactions with residues on 
the ascending and descending helices of the “stalk” (Ile1291 and Leu1162, Trp1166, and 
Leu1169, respectively).  After another hydrophobic interaction with the “barrel” (Tyr1125 
with Val1218 and Val1283), the “brace” makes an 180° turn via the clustering of Pro1132 
with Trp1123 and Trp1166. It then continues to connect to the ascending helix of the 
“stalk“ via van der Waals interactions (Val1143 with Phe1147 with Tyr1153) (Figure 
3-15).  
 
 
Figure 3-15. Evolutionary conserved interactions of the "brace". 
(a) and (b) are the zoom-in views of the Sen1Hel model , shown in a 90° and 180° clockwise 
rotation around vertical axis of the view in Figure 3-9. Selected residues are highlighted as sticks 
and show the extensive hydrophobic interactions between the “brace” and RecA1, the “stalk” or the 
“barrel”. (c) Structure-based sequence alignment of the “brace” of Sen1 and its orthologs. The 
conserved amino acids are highlighted in blue. The circles (yellow for RecA1, grey for the “stalk”’, 
and orange for the “barrel”) show with which domain a certain residue is interacting. 
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The deletions of the “brace” (constructs 1128-1904, 1136-1094, 1149-1904, and 1178-
1880) resulted in insoluble protein, most likely because upon removal of the “brace” the 
above-mentioned hydrophobic residues become exposed to the solvent. Consistently, also 
the proteins of point mutants where interaction between the “brace” and the “barrel” were 
disrupted (L1121R, W1123R, and Y1117R) were insoluble. Thus, it seems that the 
“brace” is a distinct structural feature that stabilizes the overall fold of Sen1Hel and enables 
to promote transcription termination. 
 
3.3.1.5 Accessory subdomains: the “prong” (1C)  
The subdomain 1C is the second structural feature characteristic to Upf1-like helicases 
(Figure 3-14). In Sen1Hel this 120-residue prong-like protrusion from the RecA1 domain 
(residues 1443-1563) is composed of an α-helix almost parallel to the “stalk”, two short 
α-helices at the base and a 75-residue region in between that could not be modeled (Figure 
3-9), although this region is predicted (PSIPRED) to form α-helices as well. In contrast, 
the “prong” subdomains in Upf1 and IGHMBP2 are 65 and 80-residue long, respectively. 
Although the overall structures of the three “prong” subdomains are very similar, their 
sequences are poorly conserved with the exception of a few residues that are important for 
RNA binding (see multiple sequence alignment Figure 3-11).  
 
3.3.2 RNA-binding 
Attempts to get a structure of Sen1Hel in complex with RNA failed and the following 
studies were based on the comparison of the available structures of Sen1Hel-ADP with 
Upf1CH-Hel-ADP:AlF4--RNA (Chakrabarti et al, 2011) and IGHMBP2Hel-ADP-RNA 
(Lim et al, 2012). All three proteins share conserved RNA binding motifs that enable the 
helicase to bind or translocate along the RNA. Particularly interesting is the comparison of 
RNA binding by Motif Ia and Motif III in “open” and “close” conformations of the 
helicases (Figure 3-16).  
Motif III (GDPNQLPPTSen1, GDHQQLGPVUpf1, GDHKQLPPTIGHMBP2) together with 
Motif Vb coordinates RNA binding and ATPase activity (Jankowsky & Fairman, 2007). 
In Sen1, the GDPNQ fragment (residues 1615-1619) stacks on top of Motif I with 
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Gln1619 (corresponding to Gln597Upf1 and Gln399IGHMBP2) at the position where γ-
phosphate of ATP would reside. At the other end of Motif III, the hydrophobic Leu1620 
and non-polar Thr1624 side chains stack with the interaction site between Motif Va, 
Motif V and the RNA backbone.  
Motif Ia (CAPSNAAVSen1, CAPSNVAVUpf1, CAPSNIAVIGHMBP2) is particularly 
characteristic to both DNA and RNA helicases of SF1 that translocate in 3'→5' direction. 
As there are more structures of DNA helicases available, the mechanism of how the 
helicases translocate on DNA is better understood. Here, structural studies show, that 
during translocation the base at position 5 flips in and out of Motif Ia pocket and stacks to 
Val/Thr of Motif III (Saikrishnan et al, 2009) (Figure 3-16, bottom right panel). In the 
available structures of RNA helicases such base flipping has not been observed although 
the same conserved residues are involve in RNA binding. However, in an “open” 
conformation there is enough space between Motif Ia and Motif III to fit two nucleotides 
whereas in a “close” conformation - only one nucleotide could fit. Probably, the main 
structural difference between the structures of DNA and RNA helicase of SF1 is the 
presence of accessory subdomains on RecA1. In DNA helicases, the N-terminal domain is 
pushing ssDNA to topside of RecA domains, whereas in RNA helicases the “stalk” and 
the “barrel” are pushing the RNA towards the “prong”. 
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Figure 3-16. RNA binding by Motifs Ia and III. 
Comparison of top views of nucleic acid binding sites of Sen1, IGHMBP2 (PDB: 4B3G) and 
Upf1 (PDB: 2XZL) and DNA helicase RecD2 (PDB: 3GP8). Motif Ia is shown in blue and Motif 
III is shown in orange. The nucleotides bound between the two motifs are highlighted in magenta. 
The tertiary helicase structure changes upon DNA/RNA-dependent ATP hydrolysis, the helicase 
is in an “open” conformation when bound ADP or a “close” conformation when bound to an 
ADP:AlF4  (right top panel). 
 
Sen1Hel shares the conserved residues that interact with RNA (Figure 3-17). RecA2 
residues (Tyr1752Sen1 and Arg1813Sen1 corresponding to yeast Tyr732Upf1 and Arg794Upf1) 
interact with nucleotides 1 and 2 at the 5'-end of the RNA, whereas RecA1 residues 
(Pro1622Sen1, Thr1623Sen1, Asn1413Sen1, and Thr1289Sen1 corresponding to Pro604Upf1, 
Val605Upf1, Asn462Upf1, and Thr356Upf1) approach the central portion of the RNA.  Finally, 
Sen1Hel also shares conserved residues in the “stalk” (Thr1289Sen1, Arg1293Sen1 
corresponding to Thr356Upf1, Arg360Upf1) and in the “prong” (Arg1552Sen1 corresponding to 
Arg537Upf1) that interact with ribonucleotides 6 and 7, respectively, at the 3'-end of the 
RNA. Thus unsurprisingly, a double mutant T1289A, R1293A of Sen1Hel was impaired in 
RNA binding, ATPase activity and transcription termination in vitro (Figure 3-18).  
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Figure 3-17. Comparison of the RNA-binding sites of Sen1 and Upf1. 
Most of the residues of the RNA-binding site of Sen1 and Upf1 (PDB: 2XZO) are conserved. 
 
 
 
Figure 3-18. Sen1Hel double mutant T1289A, R1293A has lost its ability to bind RNA. 
(a) RNA binding measurements by florescence anisotropy with fluorescein labeled AU-rich RNA. 
Curves represent the average of three independent experiments. The double mutation T1289A, 
R1293A of the residues of the “stalk” drastically decreases protein affinity to RNA. The 
measurements were done by Dr. Claire Basquin. (b) ATP hydrolysis assay. Values correspond to 
the average of three independent measurements. Sen1 is an RNA-dependent ATPase and impaired 
RNA binding leads to loss of ATPase activity. The measurements were done by Dr. Zhong Han. 
(c) In vitro transcription termination assay. The double mutant T1289A, R1293A is inactive for 
transcription termination. The assay was done by Dr. Zhong Han. 
 
3.3.3 The “brace” pre-positions the “barrel” for RNA binding 
One of most the prominent differences between structures of Sen1 and Upf1 helicases is 
that the latter has an additional CH domain outside the helicase core (referred to as 
Upf1CH-Hel). The CH domain regulates helicase activity in an allosteric manner.  It binds 
onto RecA2 and pushes the “barrel” towards the “prong” (Figure 3-19), this extends RNA 
binding by two nucleotides at the 3'-end of the RNA (Chakrabarti et al, 2011; Chamieh et 
al, 2008). Similarly, IGHMBP2 contains an additional R3H domain, which also has been 
shown to modulate RNA binding and ATPase activity (Lim et al, 2012). No analogous 
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allosteric regulation domain is present in Sen1 but, surprisingly, in RNase protection assays 
(see Methods 6.2.14) Sen1Hel protected the 11-ribonucleotide long fragments, more similar 
to Upf1CH-Hel than to Upf1Hel (Figure 3-19). In fact, Sen1Hel has an intrinsic feature, the 
“brace”, which might mimic the effect of the CH domain of Upf1CH-Hel on the RNA-
binding footprint by pre-positioning the “barrel” of Sen1Hel for RNA binding. 
 
         
Figure 3-19. Comparison of the "barrel" positioning in Sen1 and Upf1. 
(a) Comparison of the structures of yeast Sen1Hel, human UPF1Hel (PDB: 2GJK) and UPF1Hel-
RNA (PDB: 2XZO), and yeast Upf1CH-Hel-RNA (PDB: 2XZL). The molecules are shown in a 
front view (top) and their 90° clockwise rotations around a vertical axis (bottom). (b) RNase 
protection assay with yeast Sen1Hel, Upf1Hel, and Upf1CH-Hel in the presence of ADP:BeFx or 
ADP:AlFx. The assay was done by Fabien Bonneau. The asterisk (*) marks fragments protected by 
helicases continuously. On the left panel, a Coomassie stained SDS-PAGE gel of the proteins used 
in the assay. 
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In order to test this hypothesis, two “prong” mutants in Sen1Hel were engineered, cloned, 
expressed and purified (see Figure 3-20). In the first mutant, the part of the sequence in 
the “prong” that could not be modeled (residues 1471–1538) was replaced with a linker 
Gly-Ser-Gly-Ser (Sen1HelΔUP for upper “prong” deletion). In the second mutant, the 
entire solvent-exposed portion (residues 1461-1554) was replaced with a linker Ser-Gly-
Gly (Sen1HelΔLP for lower “prong” deletion). In RNase protection assays, Sen1HelΔUP had 
an RNA footprint similar to that of the wild-type protein, but Sen1HelΔLP resulted in a 
shorter protection of ~8-9-ribonucleotide fragments (Figure 3-20). 
 
 
Figure 3-20. Deletions reveal contribution of the “prong” to RNA binding. 
(a) The structures show the deletions of the “prong”. The dashed line represents a region of the 
upper part of the prong that was disordered in the crystal structure. The two structures depicted 
below, represent models of the two deletion constructs, Sen1HelΔUP and Sen1HelΔUP, used in the 
assay. (b) RNase protection assay with yeast Sen1Hel, Sen1HelΔUP, and Sen1HelΔLP in the presence 
of ADP:AlFx. RNA fragments were obtained by digesting 32P body-labeled 57-mer (CU)28C RNA 
with RNases A and T1. The assay was done by Fabien Bonneau. (c) A Coomassie stained SDS-
PAGE gel of the proteins used in the assay. 
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3.3.4 The “prong” is critical for RNA unwinding and transcription termination 
One function of Sen1 in the cell is processive RNA unwinding. The helicase translocates 
on ssRNA in 3'→5' direction and removes secondary structure of RNA, DNA from 
RNA:DNA duplex, or RNA-bound proteins (Jankowsky & Fairman, 2007). It is 
reasonable to expect the unwinding element to be located at the RNA entrance to the 
helicase, i.e., RecA1 domain. A close inspection of the “prong” of Sen1 and related 
helicases points out two residues.  
Firstly, Sen1Hel shares a conserved residue Arg1552Sen1 (corresponding to Arg537Upf1 and 
Lys331IGHMBP2), which in the Upf1CH-Hel structure is located near the last nucleotide of the 
RNA (Chakrabarti et al, 2011). Secondly, Sen1Hel has a hydrophobic residue, Leu1549, 
which is involved in protein-protein interaction in crystal packing as mentioned above (see 
Chapter 3.2.4). The residue is not only exposed to the surface, but also is in a close 
proximity to where the RNA is entering and the helicase might have a protein-protein 
interaction with encountered RNA-bound protein (i.e., RNA polymerase). Therefore, in 
collaboration with Dr. Zhong Han and Dr. Odil Porrua, we checked the effect of the 
“prong” deletions, Sen1HelΔUP and Sen1HelΔLP, as well as L1549D mutation for the 
helicase activity.  
All three mutants retained RNA-dependent ATPase activity (Figure 3-21, a), however, 
the full “prong” deletion in Sen1HelΔLP abolished the unwinding activity (Figure 3-21, b). 
This was not due to a decrease in the affinity for the RNA, since we observed similar RNA 
binding by Sen1HelΔLP compared to Sen1Hel (Figure 3-20). In contrast, the deletion of the 
disordered part of the “prong” in Sen1HelΔUP had the lowest ATPase activity but showed 
the highest capacity to dissociate the duplex. Interestingly, the higher the ATPase activity 
that was measured, the less active was the mutant in RNA:DNA unwinding, suggesting 
that the processivity of the helicase is not directly dependent on ATP hydrolysis rate.  
More intriguingly, Sen1HelΔUP mutant, which was the most active in unwinding assays, 
exhibited a moderate decrease in termination efficiency in vitro. (Figure 3-21, c). In 
addition, the double Sen1HelΔUP,L1549D mutant exhibited levels of duplex unwinding 
activity similar to the wild-type protein but was strongly affected in transcription 
termination. In contrast, Sen1HelΔLP mutant was inactive for both duplex unwinding and 
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transcription termination. Consistently, the full “prong” deletion leads to lethality and 
transcription termination defects in vivo (Leonaitė et al, 2017). Thus, for the first time we 
could show that both translocation and RNA unwinding are required for Sen1 to 
terminate Pol II transcription.  
 
 
Figure 3-21. "Prong" in transcription termination. 
(a) ATP hydrolysis assay. Values correspond to the average of three independent measurements. (b) 
RNA:DNA duplex unwinding assay. (c) In vitro transcription termination assay. The assays were 
done by Dr. Zhong Han. 
 
 
3.4 Sen1Hel as a model for AOA2-associate mutations in SETX 
Based on secondary structure prediction and sequence alignment, several constructs of the 
helicase domain (fragments 1671-2478, 1671-2488, 1694-2478, and 1694-2488) of human 
SETX were cloned for expression in E. coli, as described in Methods 6.2.1. The designed 
constructs were similar length to crystallized Sen1Hel, however the proteins were not 
expressed.  
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The helicase domain of SETX shares about 30 % sequence identity with Sen1Hel, including 
the key residues of the “brace” that are absent in other SF1 helicases. Thus, the disease-
associated mutations in SETX gene were tested using Sen1Hel as a surrogate. In total, 26 
missense AOA2-associated mutations (reported in LOVD Database) could be mapped 
onto Sen1Hel structure (Figure 3-22). The majority of the mutated residues are buried 
inside the helicase core, meaning that the substitution disrupt the protein fold and hinders 
the helicase activity. Other mutations affect SETX catalytic activity directly, as the 
mutated side chains are in places important for RNA recognition or ATP hydrolysis. Only 
a few residues were mapped at the surface of the helicase, however, those residues were not 
conserved. 
 
 
Figure 3-22. AOA2-associated missense mutations. 
Conserved AOA2-associated mutations mapped onto the Sen1Hel structure. The residues that 
represent SETX missense mutations (black labels) are shown as sticks in magenta. All known 
SETX mutations are reported in LOVD Database. 
 
A subset of AOA2-associated substitutions was cloned into Sen1Hel, the helicase was 
purified and tested for its enzymatic activity (Figure 3-23). A D1616V mutation of the 
residue buried at the interface between the two RecA domains resulted in an insoluble 
protein. The N1413S, P1622L and T1779P mutations targeted the residues that were 
expected to have a direct contact with RNA. These mutants were impaired in RNA 
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binding (FA measurements, Figure 3-23), and, consequently, did not elicit duplex 
unwinding and in vitro transcription termination. Finally, the R1820Q mutant that 
supposedly has a direct contact to γ-phosphate of the ATP and the substitution of which 
would impair ATP hydrolysis, was inactive in all assays. 
 
 
Figure 3-23. Characterization of the Sen1Hel harboring AOA2-associated mutations. 
(a) Selected Sen1Hel point mutations that mimic the disease mutations of SETX mapped in Sen1Hel 
structure. (b) Comparison of RNA binding affinity of the mutants measured by fluorescence 
anisotropy using fluorescently labeled AU-rich RNA as the substrate. (c) ATPase activity analysis 
of the R1820Q mutant. Arg1820 is highly conserved and coordinates γ-phosphate of the ATP. 
The point mutation was predicted to affect nucleotide binding. (d) The mutant activity in 
RNA:DNA duplex unwinding assays. The efficiency of the unwinding measured at 30 min. (e) 
Analysis of mutation impact on efficiency of transcription termination. All values correspond to the 
average and SD of three independent measurements. The assays were done by Dr. Zhong Han. 
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4 Discussion and conclusions  
4.1 Sen1Hel structure is silimilar to other Upf1-like RNA helicases of SF1 
The RNA binding and unwinding activities of Sen1 require the RecA1-RecA2 core 
domain as well as two distinct accessory subdomains that protrude from RecA1: the “stalk” 
with the “barrel” and the “prong”. Overall, the domain organization of Sen1Hel is very 
similar to the helicase core of other RNA helicases of the SF1. Consistently, Sen1Hel-ADP 
is in an “open” conformation, in which the RecA2 domain is rotated 30° outwards from 
the position observed in a “close” conformation of Upf1Hel-ATP bound structure. This 
domain movement upon ATP binding and hydrolysis is important for helicases 
translocation on a nucleic acid chain. 
In the Sen1Hel apo structure, ADP is bound to RecA1 inside the cleft. The adenine ring is 
sandwiched between RecA1 and Motif IIIa (see Figure 3-13). Motif IIIa is characteristic 
for Upf1-like helicases and resides in the linker that connects the two RecA domains. In 
SF2 helicases the adenine ring is sandwiched directly between RecA1 and RecA2 (Motif 
IVa) domains. In addition, the adenine amino group is recognized by a conserved Q-motif, 
common to all SF1 and SF2 helicases that have substrate preference for ATP over other 
nucleotides (Cordin et al, 2004). Sen1Hel also harbors Motif I and Motif II (also known as 
Walker A and Walker B) that are crucial components for ATP hydrolysis. 
Importantly, Sen1Hel binds RNA in an ATP-dependent manner. Although in RNase 
assays ADP:AlFx and ADP:BeFx were bound to Sen1Hel, no electron density for AlFx or 
BeFx moiety but for ADP was obtained. Moreover, the protein has crystallized in an 
“open” conformation that most likely leads to the reduced affinity for RNA binding.  The 
structure of Sen1Hel bound to RNA was not obtained.  
However, the RNA binding motifs are well conserved and superposition with the structure 
of Upf1Hel-RNA suggests the key residues for RNA binding (see Figure 3-17). Most of the 
RNA contacts are made with sugar phosphate backbone at the top of RecA domains; 
therefore the helicases do not discriminate between specific nucleotides or “read” the 
sequence of RNA and can also bind ssDNA. Additionally, Upf1-like helicases have an 
extended RNA binding site on the RecA1 domain. The conserved residues of Upf1-like 
helicases at nearly identical positions on surfaces of the “stalk” and the “prong” bind 
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additional three to four nucleotides. The “barrel” positioning is very important for RNA 
binding at this site and.  
 
4.2 The “brace” is unique to Sen1 
Specialized domains gained during evolution serve helicases by regulating RNA binding. 
Additional to the accessory domains (“stalk”, “barrel”, and “prong”), Upf1 and IGHMBP2 
have domains outside the helicase core that coordinate the “barrel” positioning to tune 
RNA-binding affinity and ATPase activity. When this project was started there was no 
indication that Sen1 had a similar allosteric regulation domain to modulate the positioning 
of the “barrel”. However, the crystal structure revealed that Sen1 has a unique feature, the 
“brace”, that has not been predicted as a part of the helicase domain before. It is a ~50-
residue fragment (residues 1096-1149) located upstream of the helicase domain and is well 
conserved across species. From the structure prediction or sequence alignment it was not 
possible to predict the importance of the “brace”. Although some residues, e.g. Leu1121 
and W1123, are conserved in all organisms, homology-based structural modelling has not 
predicted these two residues to interact with the barrel. However, studies in vivo had 
demonstrated that the region 1089-1135 is important for yeast viability (Chen et al., 2014), 
but the authors suggested that this region serves as a secondary nuclear localization 
sequence (NLS). The sequence motif MRKRL could indeed be assigned to Class 3 of 
NLS for the helicase import into nucleus (Kosugi et al, 2009).  
In Sen1Hel structure, the “brace” fastens the RecA1 domain, the “stalk” and the “barrel” 
together, thus the “barrel” is in a rather fixed position. Also, in comparison to other 
helicases, the linkers between the “barrel” and the “stalk” of Sen1 are the shortest and the 
“barrel” movement would be limited even if there were no “brace” present. Moreover, 
results of the RNase protection assays confirm that in Sen1Hel the “barrel” is in a position 
similar to that of the Upf1CH-Hel structure (see Figure 3-19). All together, this suggests that 
the N-terminal domain is not regulating the helicase in a similar manner to the CH or 
R3H domains of Upf1 and IGHMBP2, respectively.  
It is possible that the “barrel” conformation in the crystal structure of Sen1Hel is partially 
stabilized by crystal lattice contacts. However, the “brace” buries 2400 Å2 of the Sen1Hel 
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surface and is absolutely required. It has been shown previously that a single point mutant 
within the “brace”, W1166S, is defective in vivo (Chen et al, 2014). Moreover, the deletion 
of N-terminal residues 1-1134 in Sen1 is lethal, whereas the deletion of residues 1-1088 
does not have such a drastic effect (Chen et al, 2014). 
 
4.3 Structural basis of 5'-3' translocation of Sen1 and related RNA helicases 
Translocation and unwinding are one of the fundamental properties that define helicases. 
Structural studies of DNA helicases of SF1 revealed that the 5'→3' translocation 
directionality is achieved via alteration of the grip to DNA between RecA1 and RecA2 
domains (Saikrishnan et al, 2009). During ATP binding and closing of the cleft, the 
helicase grips the ssDNA most tightly with RecA1 domain. During ATP hydrolysis and 
opening of the cleft, the tightest grip is with RecA2 domain and as the consequence the 
“relaxed” RecA1 domain is sliding towards 3'-end of the ssDNA. 
The mechanism of how RNA helicases of SF1 translocate in 5'→3' direction is not known. 
However, Sen1 and the related helicases share conserved residues on the accessory 
subdomains that contribute to RNA binding. As it has previously been reported for Upf1 
(Chakrabarti et al, 2011), Sen1 also achieves an extended RNA-binding through conserved 
residues on the accessory domains, particularly on the “prong”. Another interesting aspect 
is that in transition between the “open” and “closed” conformations, the RecA2 domain 
rotates about 30°. In IGHMBP2Hel-ADP-RNA (PDB: 4B3G), the cleft is “open” and the 
RNA is clearly twisted but relaxed on RecA2. In the case of Upf1CH-Hel-ADP:AlF4-RNA 
(PDB: 2XZL), the cleft is “closed” and the RNA is “squeezed” (Figure 3-16). Here, 
similarly to DNA helicases (Saikrishnan et al, 2009), the fifth nucleotide of the RNA chain 
is switching between Motif III and Ia. Unfortunately, the structure of both “open” and 
“close” conformations are not available, neither for Sen1, Upf1, nor IGHMBP2, and only 
a comparison between the helicases is possible. Moreover, in RNase protection assays, the 
footprint of ground and transition states of Sen1 and Upf1 is different (Figure 3-17). 
Nevertheless, Sen1Hel shares all the conserved residues of Motifs Ia, III and V, thus the 
mechanism of how Sen1 translocates in 5'→3' direction most plausibly is similar to that of 
DNA helicases of SF1. 
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4.4 Proposed mechanism of transcription termination by Sen1 
In the NNS transcription termination pathway, the recognition of Nrd1 and Nab3 
consensus motifs is a critical first step but Sen1 is a key enzyme in facilitating the 
elongation complex dissociation. It has continuously been demonstrated that Sen1 alone is 
sufficient for termination of the elongation complex. Sen1Hel is the smallest enzyme variant 
that has been studied in transcription termination in vitro. The N- and C-terminal 
domains of the helicase are limiting Sen1 functions only in vivo (Han et al, 2017), as they 
are needed for recruitment to termination sites.  As mentioned, the CTD of Pol II directly 
or through Nab3-Nrd1 mediates timely recruitment of Sen1. However, it has not been 
shown whether a direct contact of Sen1 with surface-exposed regions of Pol II could help 
to disassemble the elongation complex.  There are though examples of other transcription 
factors, e.g. CF IA, that have been shown to bind to the evolutionary conserved flap loop 
above the RNA exit channel and to induce an allosteric signal to terminate (Pearson & 
Moore, 2014). The current model suggests that, similarly to bacterial Rho-factor, Sen1 
translocates on the nascent RNA up to the transcribing Pol II and displaces it. However, 
Rho-factor is incapable to disassemble yeast elongation complex (Porrua & Libri, 2013). 
Consistently, it has been shown that the termination efficiency increases if the polymerase 
decelerates, thus the kinetic competition between Sen1 and the Pol II plays a role. 
The results of this thesis reveal that not only translocation but also unwinding properties 
are required for Pol II termination. Sen1Hel has residues on the surface of the “prong” that 
do not have a direct effect to RNA binding or ATP hydrolysis, however are important for 
the elongation complex dissociation. For example, Sen1HelΔUP mutant, which was the 
most active in unwinding assays, exhibited a moderate decrease in termination efficiency in 
vitro (Figure 3-21). But probably more importantly, point mutation L1549D acerbated the 
effect of deletion of the upper part of the “prong”. The double mutant retained unwinding 
activity similar to wild-type protein, however termination efficiency dropped by 5-fold.  
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Figure 4-1. Sen1 in transcription termination. 
A schematic step-wise representation of Sen1 translocation along newly transcribed RNA in 5'→3' 
direction. Sen1 is a strong RNA-dependent ATPase, however it has a transient state after ATP 
hydrolysis in which the helicase is weakly bound to RNA, thus Sen1 is a low processivity enzyme. 
For efficient transcription termination it is crucial that Sen1 is either recruited in a close proximity 
to Pol II and/or that Pol II is stalled. In vivo, Sen1 is recruited to Ser2-phosphorylated Pol II via 
interaction with Nrd1-Nab3 heterodimer but also Sen1 can bind to Ser5-phospborylated Pol II 
directly.  It is still not clear whether the N-terminal domain of Sen1 is binding to the RNA and 
whether the domain is in front or behind of the helicase core during the translocation. However, 
Sen1 translocates on the transcript RNA until collides with Pol II, leading to disruption of the 
elongation complex. Most likely the close contact causes allosteric changes in Pol II, it also could 
be that Sen1 destabilizes the transcription bubble by pulling out the RNA from active site. 
 
 
4.5 SETX 
The majority of ataxia ocular apraxia type 2 (AOA2)-associated mutations are recessive 
missense, nonsense and deletion mutations that result in loss of helicase function. We have 
mapped the missense mutations onto the structure of Sen1Hel and tested 6 disease 
mimicking Sen1Hel variants in ATPase, unwinding and transcription termination assays. 
D1616VSen1 was insoluble, and all other proteins have partially or completely lost their 
enzymatic activity. Other AO2-mutations, for example E65K, W305C and P413L abolish 
binding of Rrp45 (Richard & Manley, 2014), which indicates that the N-terminal domain 
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of SETX functions as the exosome cofactor. Interestingly, none of ALS mutations cause 
direct inactivation of the helicase. For example, H1956R (Q1356Sen1) is at the back site of 
RecA2 and K2018E (L1421Sen1) is at the front site of RecA1 domain, and R2136C/H 
(K1539Sen1) is in the disordered upper part of the sidewall. The exact role of ALS4-related 
mutations remains unclear, but these mutations are dominant missense mutations that most 
likely have a gain-of-function phenotype. It could be that ALS4-related mutations impair 
SETX interaction with other proteins and ALS4 phenotype is not directly related to 
transcription termination. For instance, the most common ALS4 mutation, L389S, results 
in increased binding of SUMOylation proteins or to a peptide encoded by BCYRN1-
reverse complement (Bennet et al, 2013).  
 
4.6 Conclusions 
In this thesis the identified ~94 kDa helicase core of S. cerevisiae Sen1 has biochemical 
properties similar to those of the endogenous full-length protein in in vitro experiments. 
Sen1Hel has a very similar overall structure to that of Upf1-like helicases.  Although the 
helicases share the same conserved sequence motifs for RNA binding and ATP hydrolysis, 
Upf1 is not capable to terminate stalled Pol II in vitro. The most prominent difference in 
structures of Sen1 and Upf1 is the “brace”, which fastens the RecA1, the “stalk” and the 
“barrel” into a rigid domain. Sen1 has a relatively high ATPase activity and is capable to 
disrupt a tiny fraction of Pol II even when the “prong” is fully deleted. Interestingly, the 
processivity of the helicase seems not to be directly dependent on ATP hydrolysis but 
rather on affinity to RNA (Han et al, 2017). It could be, that relatively low processivity and 
a low copy number of Sen1 molecules per cell prevent spurious termination events.  
All together the results of this thesis support the view that Sen1 uses the nascent RNA as a 
guide to catch up with the elongation complex of Pol II moving in the same direction. 
Most likely, at direct contact, Sen1 inserts the “prong” into the RNA exit channel of Pol II 
to open the cleft of the polymerase. Additionally, surface interaction between the two 
proteins might provoke a conformational change in the elongation complex. It is also 
plausible that the elongation complex is destabilized using a “ratchet” mechanism for 
pulling the nascent RNA out of transcription burble. 
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5 Outlook 
To date it is not clear at which side of Sen1 structure the N-terminal domain resides. It 
also is not known whether the N-terminal domain can bind to RNA directly. 
Unfortunately, we could not test it in RNase assays because of the limited amount of the 
protein. And although the presence of the N-terminal domain decreases the termination 
efficiency in vitro (Han et al, 2017), it is not clear whether the domain has any regulatory 
role or the decrease is due to the large size. It is possible that the N-terminal domain 
partially interferes in interaction between the helicase domain and Pol II. These should be 
the main questions trying to solve the structures of the pre-termination complex of Sen1 
and Pol II in the future. 
Nevertheless, in in vitro experiments the helicase domain alone is capable to disassemble 
the elongation complex of Pol II. A closer inspection of the structures suggested at which 
surface of Sen1Hel and the elongation complex (PDB: 3HOV (Sydow et al, 2009)) could 
make a contact (Figure 5-1). At the collision of Sen1Hel and Pol II, the “brace”, the 
“barrel”, the “prong” together with the part of the RecA1 domain would bed in to the side 
of Pol II where the transcript is exiting. 
 
 
Figure 5-1. Interaction site on the surface of Sen1Hel and Pol II. 
At the collision of Sen1Hel with the Pol II elongation complex (PDB: 3HOV), Sen1Hel would bed 
in closely to the RNA exit channel.  
 
 
At the side of the RecA1 domain, Sen1Hel has a 20-residue loop (residues 1382-1402) that 
protrudes from the domain (Figure 5-1). PSIPRED predicted this region to be disordered 
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and only a part of the loop could be built into the model. Deletion of the loop had no 
effect on RNA binding or ATPase activity but, surprisingly, the mutant has increased 
transcription termination activity (60 % termination compared to 47 % of the wild-type 
Sen1Hel). We have not studied the mutant further, however this loop together with other 
conserved residues on the Sen1 surface should be investigated in the future. For example, 
we have also found that a double mutation on the top of the “barrel” (R1188D, Y1195F) 
has a decreased activity in transcription termination assays (40 % termination).  
On the other side, it is not known which regions of Pol II are mediating the interaction 
with Sen1 at the collision. Pearson and Moore have demonstrated that the evolutionary 
conserved flap loop of Rpb2 interacts with Pcf11 (essential for canonical transcription 
termination after polyA site), and the deletion of that loop leads to termination defects 
even at NNS-dependent noncoding genes (Pearson & Moore, 2014). Furthermore, a few 
point mutations of Rpb3 and Rpb11 at the bottom at the Pol II provoke significant 
transcription termination defects in vivo (Steinmetz et al, 2006). These residues seem to be 
too far for the helicase domain of Sen1 to reach but it could be that this is the site where 
the N-terminal domain would make the contact. 
Finally, it is not known at which distance from Pol II the helicase should be loaded on the 
transcript RNA. Currently it is suggested that Sen1 processivity is ~20-40 nt (Han et al., 
2017). However, the RNA length during Sen1 recruitment via Nrd1-Nab3 or direct 
interaction with CTD is not known and should be addressed in the future. 
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6 Materials and methods 
6.1 Materials 
6.1.1 Chemicals and reagents 
All common chemicals and reagents were ordered from Sigma-Aldrich or Fluka unless 
otherwise stated. Chemicals fot crystallization were additionally order from Hampton. 
6.1.2 Enzymes 
For DNA amplification by PCR, Phusion polymerase from Thermo Fisher Scientific was 
used. For RNase protection assays RNase A and RNase T1 (Fermentas) were used. 
Rhinovirus 3C protease was expressed and purified in-house. 
6.1.3 DNA and RNA oligonucleotides 
DNA and RNA oligonucleotides were ordered from Sigma-Aldrich and Purimex, 
respectively. All oligonucleotides were ordered desalted and lyophilized, RNA was 
additionally purified by PAGE. DNA was dissolved in ddH2O and RNA – in 100 mM 
HEPES pH 7.5 and stored at -20°C.  
Table 6-1. DNA oligonucleotides used as primers for cloning. 
 
Name Sequence (5' to 3')
1_F cacccgggatctcgagcATGAATTCCAACAATCCTG
OneStrep_R cccccatctcccggtaccgCTATTTCTCGAACTGCGGGTGGC
2231_R cccccatctcccggtaccgTCATGATCTAGGCTTTC
SM_1105_F aactttaagaaggagatatacatATGAGAAAGAGATTAAATGTTG
SM_1105_R CAACATTTAATCTCTTTCTCATatgtatatctccttcttaaagtt
ins3C_F gtggttctgttccaggggcccCTCGCGGGCGGTAAAATACTCCATAATC
ins3C_1881_R ctggaacagaaccaccagTGATGGTACGGGTACATTGAACTTTC
ins3C_1904_R ctggaacagaaccaccagATTGGATTTTACCTCATCGGGGCCTTGCG
ins3C_1910_R ctggaacagaaccaccagTCTCTTCTTTGTGTCCTTATTGGATTTTACC
T4L_1_R GGTGGTGGTGGTGGTGGTGGTGtccCAGGTTCTTGTAAGCGTCCC
T4L_2_F GGGACGCTTACAAGAACCTGggaCACCACCACCACCACCACCACC
Trx_1_R GGTGGTGGTGGTGGTGGTGGTGtccCAGGTTAGCGTCGAGGAACTC
Trx_2_F GAGTTCCTCGACGCTAACCTGggaCACCACCACCACCACCACCACC
43_1_F GAAAGTTCAATGTACCCGTACCATCACTGGAAGTTCTGTTCCAGGG
GCCCATGAACATCTTCGAGATGCTGCG
43_2_R CGCAGCATCTCGAAGATGTTCATGGGCCCCTGGAACAGAACTTCCA
GTGATGGTACGGGTACATTGAACTTTC
44_1_F GGCCCCGATGAGGTAAAATCCAATCTGGAAGTTCTGTTCCAGGGGC
CCATGAACATCTTCGAGATGCTGCG
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44_2_R CGCAGCATCTCGAAGATGTTCATGGGCCCCTGGAACAGAACTTCCA
GATTGGATTTTACCTCATCGGGGCC
45_1_F ATCCAATAAGGACACAAAGAAGAGACTGGAAGTTCTGTTCCAGGGG
CCCATGAACATCTTCGAGATGCTGCG
45_2_R CGCAGCATCTCGAAGATGTTCATGGGCCCCTGGAACAGAACTTCCA
GTCTCTTCTTTGTGTCCTTATTGGAT
46_1_F AAGTTCAATGTACCCGTACCATCACTGGAAGTTCTGTTCCAGGGGC
CCATGAGCGATAAAATTATTCACCTG
46_2_R CAGGTGAATAATTTTATCGCTCATGGGCCCCTGGAACAGAACTTCC
AGTGATGGTACGGGTACATTGAACTT
47_1_F GGCCCCGATGAGGTAAAATCCAATCTGGAAGTTCTGTTCCAGGGG
CCCATGAGCGATAAAATTATTCACCTG
47_2_R CAGGTGAATAATTTTATCGCTCATGGGCCCCTGGAACAGAACTTCC
AGATTGGATTTTACCTCATCGGGGCC
48_1_F GTAAAATCCAATAAGGACACAAAGAAGAGACTGGAAGTTCTGTTCC
AGGGGCCCATGAGCGATAAAATTATTCACCTG
48_2_R CAGGTGAATAATTTTATCGCTCATGGGCCCCTGGAACAGAACTTCC
AGTCTCTTCTTTGTGTCCTTATTGGATTTTAC
IA2_41_R2 CAGTCTGAGGCAGATTTCGTCCACAGCGGCATTACTGGGGGC
IA4_41_R2 ccttcttaaagttaaacaaaattatttctagagggg
IA6_41_R2 TACACGGACCAATTGAGGTTTAAATTGATGCCCC
IA7_41_R2 CATTACAATTAAGTCAGATTCAGAAATACCAC
IA1_41_F GGTTACTTTTTGTCTACAAAGAATGCCTCAggtggtAAGCAAAAAATTC
TAATCTGTGCCCCCAG
IA1_41_R AATAATACCCAGTATAGTCTTTG
IA2_41_F GAAATCTGCCTCAGACTGAAGAGTGGAggtggtggtTTGGTCCGTGTAG
GTAGGTC
IA2_41_R GTCCACAGCGGCATTACTGG
IA3_41_F GGACCTTACTTTAGAAGAACTTagcggtggtCAGGCCCATATCTTGGCG
GTTAGTG
IA3_41_R TTAATTGCAACGTTTACAACGTC
IA4_41_F gtttaactttaagaaggagatatacatATGAATAGTGAATATCCTGATGATGAGCCTA
TTGG
IA4_41_R aaaattatttctagagggg
IA5_4_IA4_F CATGAAGCCTTTACTACTTCTAGAATCTTcGCAAGGTaacTGTTCTTC
ACGTGATAGAGAGGAC
IA5_4_IA4_R ACTTTTTGGTAGTCAGCAGGAG
IA6_41_F CCTCAATTGGTCCGTGTAGGTggcggcggcATTAAGGACCTTACTTTAG
IA6_41_R TTTAAATTGATGCCCCTG
IA7_41_F GACTTAATTGTAATGGCTTATggcggcCATACATGTTTAGCAAAGGTG
IA7_41_R AGATTCAGAAATACCACAATCC
IA8_41_F CAACATACATGTTTAGCAgAGGTGAGAACATTGAAAAATACC
IA8_41_R TGCTTTCTTGAAATCATCACTGGAC
IA9_41_F CCTCTATATGAAATCATAagGCAATGGGATTACACCAG
IA9_41_R GTTCATATCAACATTTAATCTCTTTCTCATATGTTC
IA10_41_F CCTCTATATGAAATCATAagGCAAtgGGATTACACCAGAAATAGTG
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Small letters show overhangs of vector sequence or introduced mutations. Capital letters 
correspond to the sequence of the gene of interest.  
 
Table 6-2. ssDNA/RNA used in assays. 
 
 
6.1.4 Constructs 
All S. cerevisiae variants were cloned into pCB-A-bax10 plasmid (kindly shared by Dr. 
Christian Biertümpfel) for expression in E. coli and into pFLΔSpeI donor plasmid 
(Invitrogen) for expression in insect cells. See list of all cloned mutants in Appendix 3. 
6.1.5 Cloning kits 
Wizard Gel and PCR Clean-up (Promega) and Qiaquick Spin Miniprep (Qiagen) kits 
were used. 
IA11_41_F GTTGATATGAACCCTCTAaggGAAATCATATTGCAATGGG
IA11_41_R ATTTAATCTCTTTCTCATATGTTC
IA12_41_F GTTGATATGAACCCTCTAaggGAAATCATAagGCAATGGGATTACAC
CAG
IA13_41_F CACAACATACATGTTTAGCAAAGGTGgaAACATTGAAAAATACCAA
AGGTGG
IA13_41_R CTTTCTTGAAATCATCACTGGAC
IA14_41_F GGTAATGTTGATGTCACATTAgaaATTCATAGAAATCATTCTTTCAG
TAAATTTTTGAC
IA14_41_R ACCTTTGGTATTTTTCAATGTTCTCACC
IA15_41_F gtttaactttaagaaggagatatacatATGTCTCCTGCTGACTACCAAAAAGTCATGA
AGCC
IA16_41_F gtttaactttaagaaggagatatacatATGCCTATTGGTAATTATTCTGACGTAAAG
GATTTCTTC
IA10_41_F CCTCTATATGAAATCATAagGCAAagGGATTACACCAGAAATAGTG
IA19_41_F GAGATTAAATGTTGATATGAACCCTCTAgctGAAATCATAgcgCAAgcg
GATTACACCAGAAATAGTGAATATCCTG
Name Sequence
16-mer RNA oligonucleotide used for UGCAUUUCGACCAGGC 
assembly of ECs. 5'-end FAM labeled
Template DNA strand used for assembly  GGCCGGGTAACCCCCGTGTGGAGATGGGTGAGAGATGTTG
of ECs. Labeled with biotin at the 5'-end AGGGCCTGGTCGTTTCCTATAGTTTGTTTCCT 
Non-template strand usedfor assembly  CTAGAGGAAACAAACTATAGGAAACGACCAGGCCCTCAAC
of Ecs. Labeled with biotin at the 5'-end ATCTCTCACCCATCTCCACACGGGGGTTACCCGGCCTGCA 
ssDNA/RNA for ATPase assay UUUUUUUUUUUUUUU
5'-end FL labeled CCCCCCCCCCCCCCC
AAAAAAAAAAAAAAA
CCCTAACCCTAAC
RNA for FA measurements UUUCUAUUUAUUUUG 
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6.1.6 E. coli strains and insect cell lines 
 
Table 6-3. E. coli strains used for cloning and expression. 
 
 
For protein expression in insect cells the Autographa californica cell lines Sf21 and 
HighFive (Invitrogen) were used.  
6.1.7 Media and buffers 
 
Table 6-4. Media used for cloning and protein expression. 
 
E. coli strains Genotype
One Shot™ OmniMAX™ 2 T1 F′ {proAB+ lacIq lacZ∆M15 Tn10(TetR) ∆(ccdAB)} mcrA 
(Thermo Fisher Scientific) ∆(mrr-hsdRMS-mcrBC)∆M15φ80(lacZ) ∆(lacZYA-argF)  
U169endA1 recA1 supE44 thi-1 gyrA96 relA1 tonA panD
DH10MultiBacY F– mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74
(Invitrogen) recA1 endA1 araD139 Δ(ara, leu)7697galUgalKλ–  
rpsLnupG/bMON14272/pMON7124
BL21 (DE3) STAR pRARE F- ompT hsdSB (rB -mB -) gal dcm rne131 (DE3) (pRARE 
(Stratagene) araW argU glyT ileX leuW proL metT thrT tyrU thrU CamR) 
Media Components
S.O.C.	Medium	 2	%	(w/v)	bacto	tryptone		
	0.5	%	(w/v)	bacto	yeast	extract
10	mM	NaCl
1	mM	MgCl2
2.5	mM	KCl
10	mM	MgSO4
0.4	%	(w/v)	glucose
adjust	pH	to	7.2
Luria-Bertani	(LB)	 1	%	(w/v)	bacto	tryptone
(Miller,	1972) 0.	5%	(w/v)	bacto	yeast	extract
170	mM	NaCl
adjust	pH	to	7.6	
LB	agarose	plates	 1.5	%	(w/v)	bacto	agar	in	LB	
100	µg/mL	ampicillin
Terrific	Broth	(TB) 1.2	%	(w/v)	bacto	tryptone
(Sambrook	&	Russell,	2001) 2.4	%	(w/v)	bacto	yeast	extract
0.4	%	(v/v)	glycerol
ddH2O	to	900	ml
0.017	M	KH2PO4
0.072	M	K2HPO4
Sf-900TM	SFM Purchased	from	Invitrogen
(insect	cell	culture	medium)
ESF	921 Purchased	from	Expression	Systems
(insect	cell	culture	medium)
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Table 6-5. Protein purification buffers. 
 
 
Table 6-6. Sample freezing buffer. 
 
 
Buffer Components
Lysis buffer 20 mM sodium phosphate pH 8.0
500 mM Nacl
2 mM MgCl2
30 mM imidazole
10 % (v/v) glycerol
1 mM β-mercaptoethanol
Salt wash buffer 20 mM sodium phosphate pH 8.0
1000 mM Nacl
2 mM MgCl2 
30 mM imidazole
1 mM β-mercaptoethanol
ATP wash buffer 20 mM sodium phosphate pH 8.0
250 mM Nacl
2 mM MgCl2 
50 mM KCl
10 mM MgSO4
2 mM ATP
1 mM β-mercaptoethanol
Tag cleavage buffer 20 mM Tris-HCl pH 7.5
250 mM Nacl
2 mM MgCl2
10 % (v/v) glycerol
1 mM β-mercaptoethanol
Buffer A 20 mM Tris-HCl pH 7.5
250 mM Nacl
2 mM MgCl2
1 mM DTT
Buffer B 20 mM Tris-HCl pH 7.5
1000 mM Nacl
2 mM MgCl2
1 mM DTT
SEC buffer 20 mM HEPES pH 7.5
250 mM NaCl
2 mM MgCl2
1 mM DTT
Buffer Components
Sample	freezing	buffer	(2x) 40	mM	HEPES	pH	7.5
250	mM	NaCl
2	mM	MgCl2
99	%	(v/v)	glycerol
1	mM	DTT
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Table 6-7. Buffers used in assays. 
 
Table 6-8. PAGE gels. 
 
 
 
Buffer Components
TBE	(20	x) 1	M	Tris-HCl
0.89	M	boric	acid
20	mM	EDTA	pH	8.0
SDS-PAGE	running	 0.25	M	Trizma	Base
1.92	M	Glycine
1%	(v/v)	SDS
SDS	loading	buffer	(2x) 100	mM	Tris	pH	6.8
4%	(v/v)	SDS
0.2%	(v/v)	bromphenol	bue
20%	(v/v)	glycerol
10%	β-mercaptoethanol
RNase	protection	(2x) 100	mM	HEPES	pH	7.5
100	mM	NaCl
2	mM	MgAc2
0.2	%	(v/v)	NP-40
20	%	(v/v)	glycerol
Splicing	dilution	buffer 100	mM	Tris	pH	7.5
150	mM	NaCl
300	mM	Na	acetate	pH	5.2
10	mM	EDTA
1%	(v/v)	SDS
100	%	BFE 0.1	%	bromphenol	blue
0.1	%	xylene	cyanole	FF
10	mM	EDTA	pH	8.0
formamide
Gel Components
Stacking SDS-PAGE gel 2.63 mL ddH2O
2 mL 1.5 M Tris pH 8.7
800 µL 30 % (w/v) N,N’-methylene-bisacrylamide (37.5:1)
40 µL 10 % (w/v) SDS
24 µL 10 %  (w/v) ammonium persulfate (APS)
8 µL 100 % N, N, N’N’-tetramethylethylene diamine (TEMED)
Separating SDS-PAGE 3.4 mL ddH2O
(10 %) 2 mL 1.5 M Tris pH 8.7
2.6 mL 30 % (w/v) N,N’-methylene-bisacrylamide (37.5:1)
80 µL 10 % (w/v) SDS
36 µL 10 %  (w/v) ammonium persulfate (APS)
12 µL 100 % N, N, N’N’-tetramethylethylene diamine (TEMED)
Denaturing PAGE gel 7 M urea
(22 %) 22 mL  30 % (w/v) N,N’-methylene-bisacrylamide (19:1)
180 µL 10 %  (w/v) ammonium persulfate (APS)
30 µL 100 % N, N, N’N’-tetramethylethylene diamine (TEMED)
to 30 mL 1x TBE
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6.1.8 Equipment 
 
Table 6-9. List of equipment. 
 
 
6.1.9 X-ray sources and synchrotron facility 
Crystals were tested with in-house X-ray diffractometers PX-scanner (Rigaku) and D8 
venture (Bruker). Some of the diffraction data sets were also collected on in-house D8 
venture, however the higher resolution data sets were obtained at Swiss Light Source 
(SLS) synchrotron at the Paul Scherrer Institute (PSI), Villingen, Switzerland.  
Equipment Model Manufacturer
Pipettes Eppendorf Research Eppendorf
Scales LA1200S & TE1502S Sartorius
pH meter Lab860 Schott
PCR machine Mastercycle Eppendorf
UV transilluminator Safe Imager Invitrogen
Vortex mixer Vortex-Genie Scientific Industries
Electroporator Gene Pulser/Micro Pulser Bio-Rad
Electro-cuvette Gene pulser 0.1 cm electrode gap Bio-Rad
Bacteria shaker KS-15/Climo-shaker ISF1X Kühner 
Thermo shaker Thermomixer Comfort Eppendorf
Cell lysis sonicator Sonifyer VS70T Bandelin Electronics
Insect cell shaker Kühner shaker Kühner 
Laminal flow hood Holten LaminAir Thermo electron corporation
Cell counter Vi-Cell-XR Beckman Coulter
Dounce Homogenizer Borosilicate Glass Thermo Fisher Scientific
Centrifuge Avanti J-20 XP Beckman Coulter
Micro centrifuge 5417C & 5810 Eppendorf
Columns Ni2+-NTA beads & HisTrap FF GE Healthcare
HiTrap Heparin HP 
Superdex 200 [16/600]
Peristaltic pump Ismatec 78001-40 Cole-Parmer
Chromatography FPLC ÄKTA Prime GE Healthcare
ÄKTA Purifier
Protein concentrator Amicon Ultra Centrifugal filters  Ultracel
Spectrophotometer Nanodrop PeqLab
Gel imaging Gel visualization Roth
Crystallization plates 96-well MRC96T SwissCl
24-well vdx Hampton Research
Crystallization pipetting robot Phoenix Art Robbins Instruments
Crystallization visualization system Xtal-Focus ExploraNova La Rochelle
Cryo loops CryoLoop 20 micro Hampton Research
Caps and vials Magnetic caps and vials Molecular Dimensions
X-ray diffractometer PX scanner Rigaku
D8 venture Bruker
Fluorescence spectrometer Infinite M1000 Pro Tecan
Phosphorimager Typhoon FLA 9500 Fuji
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6.1.10 Software and web servers 
The following software was used to write this thesis, analyze data and generate figures: 
Adobe Illustrator (www.adobe.com/products/illustrator) 
ApE (http://biologylabs.utah.edu/jorgensen/wayned/ape/) 
BIOEQS (http://abcis.cbs.cnrs.fr/BIOEQS/) 
Buccaneer (http://www.ccp4.ac.uk/html/cbuccaneer.html) 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/)  
CodonCode Aligner (http://www.codoncode.com/aligner/)  
Coot (http://www2.mrc-lmb.cam.ac.uk/Personal/pemsley/coot/)  
EndNote X7 (http://endnote.com)  
Hampton Research Make-tray tool (http://hamptonresearch.com/make_tray.aspx)  
Jalview (http://www.jalview.org/)  
Microsoft Office (www.microsoft.com)  
LigPlot (https://www.ebi.ac.uk/thornton-srv/software/LIGPLOT/) 
LOVD Database (https://databases.lovd.nl/shared/variants/SETX/unique) 
Phenix (http://www.phenix-online.org)  
Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2)  
ProtParam (http://web.expasy.org/cgi-bin/protparam)  
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/)  
PyMOL (http://pymol.org)  
SHELX (http://shelx.uni-ac.gwdg.de/SHELX/)  
UNIPROT (http://www.uniprot.org)  
wwPDB (https://www.wwpdb.org) 
XDS (http://xds.mpimf-heidelberg.mpg.de) 
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6.2 Methods 
6.2.1 Cloning for expression in E. coli 
For cloning a one-step ligation-independent method was used. The method relies on 
DNA repair machinery of E. coli cells. For each transformation a set of a linearized vector 
and an insert with the >25 bp extensions were designed (Figure 6-1, a). In case of cloning a 
point mutation, a vector was linearized using primers that harbored the mutation (Figure 
6-1, b). After PCR, purified unprocessed DNA was directly transformed into cells. All the 
constructs were cloned into a pCB-A-bax10 plasmid (kindly shared by Dr. Christian 
Biertümpfel) that contained a cleavable C-terminal His tag coupled to Vibrio cholerae 
MARTX toxin cysteine protease domain (CPD-His8) (Shen et al, 2009). 
 
 
Figure 6-1. Schematic presentation one-step ligation-independent cloning. 
(a) Cloning with a linearized vector and an insert. The insert (red) encodes Sen1 sequence and the 
>25 bp extensions at both ends. These extensions are identical to the sequence of the vector (navy). 
After transformation, under selective ampicillin pressure, the cell is forced to repair the plasmid and 
recombines the insert with the DNA containing the Ampicillin-resistance cassette (yellow).  (b) 
Cloning of a point mutation. The vector is linearized using primers that encode a point mutation 
(light blue). Both ends if linearized vector are identical. After transformation the cells repairs the 
plasmid to gain ampicillin resistance.  
 
6.2.1.1  PCR 
The PCR reactions for vector linearization and the inserts were set up in a total volume of 
50 µL: 
5 µL forward primer (10 µM) 
 5 µL reverse primer (10 µM) 
 20 ng template DNA 
 2.5 µL DMSO 
 25 µM 2x Master Mix buffer (kit) 
 0.5 µM Phusion Polymerase (1 U/µL)  
Materials and methods 
 
 
 
84 
The following thermocycling conditions were used: 
 1-3 min - 98°C initial denaturation  
 10 s - 98°C denaturation* 
 10 s - Tm-5°C annealing* 
 30 s per kb - 72°C extension* 
 10 min - 72°C final extension 
* Steps were repeated in 30-35 cycles. The annealing temperature varied depending on the 
melting temperature (Tm) of the primers. In some cases touch-down PCR was applied with the 
decrease of the annealing temperature of 1°C per cycle. 
6.2.1.2  Agarose gel electrophoresis 
DNA fragments of PCR products were separated on 0.75 % (w/v) agarose gels prepared in 
1x TBE, supplemented with SYBR Safe (Invitrogen) stock 1:10000 dilution as a dye for 
visualization. Prior to loading samples were mixed with 6x loading buffer (Orange Loading 
Dye, Fermentas). 0.5 µg of the 1Kb Plus DNA ladder (Fermentas) was used as a marker in 
a separate lane. Gel electrophoresis was performed at 6 V/cm in 1x TBE buffer. DNA 
fragments were visualized and excited from the gel using a blue light transilluminator 
(Invitrogen) emitting light at a wavelength of ~470 nm. 
6.2.1.3  DNA fragment purification 
The separated DNA bands from an agarose gel were purified with the Wizard SV Gel and 
PCR Clean-up system (Promega) according the manufacturer’s protocol. All DNA 
fragments were eluted in 30 µL ddH2O. 
6.2.1.4  Transformation 
The purified linearized vector and the insert (1.5 µL and 3.5 µL each) were added to 50 µL 
aliquots of OmniMAX chemically supercompetent E. coli cells. Cells were then gently 
mixed and incubated on ice for 5 min. A heat shock was performed in order to transfer the 
vectors into bacteria cells. Therefore, the mixture was incubated 45 s at 42°C and then 
chilled on ice for 2 min followed by addition of 600 µL of S.O.C. medium and incubation 
at 37°C, 600 rpm for 30 min. Next, 100-300 µL of the cells were plated on LB agar plates, 
supplemented with 100 µg/mL ampicillin, and incubated over night at 37°C. 
6.2.1.5  Plasmid amplification and isolation 
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For plasmid amplification a single-cell-derived colony from the E.coli agar plate was picked 
with a pipette tip and added to 5 mL LB medium supplemented with 100 µg/mL 
ampicillin. The cell culture was incubated over night 160 rpm at 37°C. The cells were 
harvested by centrifugation (4000 rpm / 10 min / 4°C). Plasmid DNA was purified with 
Wizard Gel and PCR Clean-up System kit (Promega) and eluted in 50 µL ddH2O. The 
concentration of plasmid was measured with the Nanodrop spectrophotometer.  
6.2.1.6  DNA Sequencing 
All plasmid DNA was sequenced by the core facility of MPI Biochemistry or Eurofins. 
Custom sequence primers were ordered with the aim for a GC content of at least 45% and 
Tm ~65°C. The received nucleotide sequence was analyzed and compared to the 
nucleotide sequence of the original gene using CodonCode Aligner and ApE programs.  
6.2.2 Recombinant protein expression in E. coli 
 
For the recombinant protein expression in E. coli a plasmid was transformed to BL21 
(DE3) STAR pRARE cells as described before. The successful transformation was 
selected by incubating 100 µL of the cells on LB agar plates containing 100 µg/mL 
chloramphenicol and 100 µg/mL ampicillin. Next day a small amount of cells was scraped 
from a single colony into 70 mL LB media supplemented with respective antibiotics and 
incubated at 37°C and 200 rpm for 2-3 hours. 10 mL of pre-culture was added to pre-
warmed 500 mL TB media supplemented with respective antibiotics, and incubated 
further at 37°C and 220 rpm until OD600 ~1.5 (3-4 hours). Then the temperature was 
decreased to 18°C and 0.5 mM IPTG was added to induce protein expression. After over 
night expression (~16 hours), cells were harvested by centrifugation (9 000 x g, 10 min). 
The cell pellet was either used immediately or flash frozen in liquid nitrogen and stored at 
-80°C. 
6.2.3 Cloning and expression in insect cells 
For recombinant protein expression in cultured insect cells a recombinant baculovirus has 
to be generated in two steps (Figure 5-1).  First, a donor plasmid is created and then the 
plasmid is transformed into competent E. coli cells that contain the bacmid (baculovirus 
shuttle vector) for site-specific transposition. Afterwards, the recombinant bacmid DNA is 
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used for insect cell transfection (virus generation), followed by virus amplification and 
recombinant protein expression. 
 
 
Figure 6-2. Generation of recombinant baculovirus and protein expression. 
After a recombinant plasmid is generated, it has to be transformed into bacmid. The recombinant 
bacmid DNA then is used for insect cell transfection to generate the virus. During virus cycle the 
infected cells are killed which leads to virus release to media and infection of new insect cells. After 
the virus has been amplified (P1 → P2 → P3), the recombinant protein expression can be tested. 
 
 
6.2.3.1 Donor plasmid cloning and bacmid generation 
All the cloning procedures for expression in insect cells were done as described in Methods 
6.2.1 with the following exceptions. DNA encoding full-length S. cerevisiae Sen1 was 
cloned into multi cloning site 1 (MCS1) of pFLΔSpeI donor plasmid (Figure 6-3). Sen1 was 
placed downstream p10 promoter that is required for the expression in insect cells when 
using the Bac-to-Bac Baculovirus Expression System (Invitrogen). In this system, the 
transcriptional control of the Autographa californica nuclear polyhedrosis virus results in 
abundant heterologous gene expression at the late stage of infection, while host proteins 
synthesis is diminished. 
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Figure 6-3. pFLΔSpeI plasmid map. 
pFLΔSpeI is a donor plasmid used to generate recombinant viruses. The plasmid contains one origin 
of replication and can be propagated in E. coli. The multiple cloning sites (MCS1 and MCS2) 
contain several restriction sites for gene insertion and are flanked by Tn7 elements (Tn7L and 
Tn7R) for transposition to the attTn7 attachment sites on the bacmid. Additionally, these 
elements contain an expression cassette consisting of a Gmr and Apr genes and an SV40 poly(A) 
signals.  
 
The newly cloned donor plasmid has to be then transposed into a bacmid. The 
transposition is based on site-specific transposition of an expression cassette into a bacmid 
DNA propagated in E. coli. The donor plasmid contains mini-Tn7 element that attaches 
to mini-attTn7 on the bacmid. The required Tn7 transposase is provided by helper 
plasmid that is hosted by competent cell. The lac operator controls the successful 
transposition as the bacmid contains a segment of DNA encoding the lacZα peptide. 
Insertion of the mini-Tn7 into the mini-attTn7 attachment site on the bacmid disrupts 
peptide’s expression and the colonies containing the recombinant bacmid are white in 
background of blue non-transposed colonies. Additionally, the bacmid and the helper 
plasmid confer resistance to kanamycin and tetracycline, respectively.  
Here, for the transposition the verified pFLΔSpeI plasmid was transformed into 
DH10EmBacY E. coli strain by electroporation. Therefore, 2 µL of plasmid DNA were 
added to 50 µL competent cells and incubated for 5 min on ice. Then the cells were 
transferred into electrophoresis cuvette. Immediately after the electroporation at 2.5 kV 
900 µL S.O.C. medium was added and the culture was incubated at 37°C and 600 rpm for 
over night. The successful transformation was selected by blue-white screen. Therefore, 
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100-300 µL of the cells were plated on LB containing 50 µg/mL kanamycin, 7 µg/mL 
gentamicin, 10 µg/mL tetracyclin, 100 µg/mL Bluo-gal (dissolved in DMSO) and 80 
µg/mL IPTG.  The bacmid was amplified by growing 2 mL bacteria culture in LB from 
an isolated white colony as described previously. The selective pressure was maintained by 
adding 50 µg/mL kanamycin, 7 µg/mL gentamicin, and 10 µg/mL tetracyclin. Finally, the 
bacmid was isolated by alkaline lysis, using the Qiaprep Spin Miniprep kit, and DNA 
precipitation in isopropanol and dissolved in 30 µL ddH2O. 
6.2.3.2 Transfection of Sf21 insect cells and virus generation 
During the transfection, Sf21 cells are infected with the recombinant bacmid DNA. To 
significantly increase the efficiency, the DNA has to be incubated with transfection agent 
such as polyethylenimine (PEI) that acts as an attachment factor for cell adherence. Both 
PEI are polycationic polymers and condense DNA into positively charged particles, which 
bind to anionic cell surface residues and are brought into the cell via endocytosis.  Once the 
vesicle enters the cell, it undergoes osmotic swelling and bursts releasing the polymer-
DNA complex into the cytoplasm. Then the polymer is replaced by other cations leading 
to unpacked bacmid DNA. The bacmid then can enter the nucleus where viral 
transcription and replication occurs. The baculovirus particles get budded outwards the cell 
by 24-72 h post-infection to spread the infection. In this time the recombinant protein is 
also expressed. 
The initial virus titer and volume is too low for sufficient recombinant protein expression 
and thus several cycles (P1 → P2 → P3) of virus harvesting and new infection are required 
(Figure 6-4). Therefore, the infected insect cells were centrifuged and the supernatant with 
virus P1 was used to infect the larger amount of Sf21 insect cells. This procedure was 
repeated two more times and the final P3 virus was used further for protein expression in 
HighFive insect cell line. The cell growth and lysis was monitored throughout the virus 
generation using cell counter Vi-Cell-XR (Beckman Coulter). 
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Figure 6-4. Virus generation in Sf21 insect cells. 
Schematic representation of the virus generation. Three rounds of new cell culture infection were 
required to increase volume and virulence of virus stocks.  
 
6.2.3.3 Recombinant protein test-expression in HighFive insect cells 
In order to test recombinant protein expression in HighFive insect cell line, the same 
amounts of the cells (106 cells/mL in 3 mL) were infected with 0.15-300 µL of P3 virus to 
find out the optimal amount of virus. After 3 days of the expression, 400 µL of the infected 
cell cultures were centrifuged at 27°C and 800 x g for 15 min. The supernatant was 
removed and the pellet was dissolved in 4x SDS sample buffer for Western blot analysis. 
6.2.4 Protein purification 
6.2.4.1  Cell lysis 
The cell pellet was thawed and resuspended in 100-300 mL lysis buffer supplemented with 
benzonase and protease inhibitor cocktail. All purification steps were done at 4°C. The 
cells were lysed using a sonificator at 40 % intensity for 0.5 s with 0.5 s break intervals until 
the cells were completely disrupted (8-15 min). After sonification cell debris and insoluble 
materials were removed by centrifugation (75 000 x g, 45 min) and the supernatant was 
filtered through 5-µm membrane (Millex-VG) for a further purification of the target 
protein. 
6.2.4.2  Ni2+-NTA affinity chromatography 
The cleared lysate was passed over 5 mL Ni2+-NTA beads (GE Healthcare), pre-
equilibrated in the lysis buffer. The column was then washed with 250 mL high salt wash 
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buffer to remove contamination. An additional wash with 250 mL ATP wash buffer was 
performed to remove persistent chaperon contamination. Finally, 100 mL Ni Buffer A was 
passed through the column. The sample was eluted by ‘on-column’ tag cleavage with 
recombinant HRV 3C protease over night.  
6.2.4.3  Ion exchange chromatography 
To increase the purity of the protein, the elution fraction of Ni2+-affinity was loaded to 
pre-equilibrated HiTrap Heparin HP column (GE Healthcare) using Buffer A for 
binding. A stepwise 20 % wash with Buffer B removed protein still containing nucleic acid 
contamination. Finally, Sen1 was eluted with a gradient over 4-6 CV to 100 % Buffer B. 
The purest fractions were pooled and used for further purification by size exclusion 
chromatography. Alternatively, the sample was centrifuged at 4000 g using 15 mL Amicon 
Ultra Centrifugal filters (Ultracel) concentrators with a molecular weight cut off (MWCO) 
of 50 kDa and flash frozen in liquid nitrogen and stored at -80°C. 
6.2.4.4  Size exclusion chromatography 
Shortly before injecting onto Superdex 200 [16/600] (GE Healthcare) the sample was 
again centrifuged in an eppendorf tube at 13.000 x g for 5 min to pellet insoluble 
components. The chromatography flow rate was set up at 0.5 mL/min, fractions of 0.5-1 
mL were pooled and concentrated to 10-15 mg/mL. 
6.2.5 SDS-PAGE 
Every step of protein purification was analyzed on Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) gels with 10% (w/v) acrylamide 
(according to Laemmli, 1970). The respective samples were mixed with 2 x SDS loading 
dye and denatured at 95°C for 2 min. 10 µL of each sample was loaded. As a marker 3 µL 
of PageRuler unstained protein ladder (Thermo Fisher Scientific) was also loaded on the 
gel. Electrophoresis was performed in tanks with 1x SDS running buffer at 200 V until the 
running front reached the bottom of the gel. Thereafter, the gel was stained with 
Coomassie Brilliant Blue. 
6.2.6 Denaturing PAGE 
Denaturing PAGE was used to analyze RNA or DNA samples (according to (Summer et 
al, 2009). For RNase protection assays the samples were subjected to 22 % (w/v) 
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denaturing PAGE with 5 M urea.  For RNA:DNA duplex unwinding and in vitro  
transcription termination assays the samples were subjected to 15 % (w/v) denaturing 
PAGE (8 M urea) and 10% (w/v) denaturing PAGE (8 M urea), respectively.  
6.2.7 Western-blot 
For Western-blot analysis, 15 µL of samples were loaded on 10 % SDS-PAGE gel to 
separate proteins by their size. After electrophoresis, the gels were incubated in Transfer 
buffer (20 mM trizma base, 150 mM glycine, 0.1 % SDS, 20 % methanol) for 15 min and 
the proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane (Merck 
Millipore) for 80 min at 200 mA using cold Transfer buffer. To fix the transferred 
proteins, the membrane was incubated in 10 % HOAc for 15 min and air-dried. 
Afterwards rehydration in 1x Tris-buffered saline (TBS, 50 mM Tris pH 7.5, 150 mM 
NaCl) the membrane was blocked with 5 % non-fat dry milk in 1x TBS to prevent non-
specific antibodies binding to the membrane by incubating for 1 h at room temperature, 
washed two times with TBS containing 0.05 % Tween 20, and once with TBS.  Then the 
proteins were detected with the mouse anti-HA-tag antibodies followed by incubation 
with horseradish peroxidase (HRP) conjugated anti-Mouse secondary antibodies. 
Alternatively, the membranes were stained with Ponceau S solution (Sigma-Aldrich). 
6.2.8 Measurements of protein concentration 
Proteins concentrations were determined using a spectrophotometer (Nanodrop) to 
measure the UV absorbance of proteins at 280 nm. Extinction coefficient was calculated 
with ProtParam. The protein concentration (mg/mL) was calculated equal to 
Absorbance280 (mg/mL)/extinction coefficient. 
6.2.9 Protein storage 
For short storage proteins were kept at 4°C or on ice. If needed to store for longer period, 
the proteins were mix with Sample freezing buffer (40 mM HEPES pH 7.5, 300 mM 
NaCl, 2 mM MgCl2, 99% (w/v) glycerol) and stored at -80°C or at -20°C. 
6.2.10 Mass spectrometry 
For mass spectrometry analysis protein sample bands from SDS-gels were cut out or, 
alternatively, a liquid protein sample was analyzed. The peptide fingerprinting was used to 
determine the region that was cleaved endogenously during Sen1976-1880 purification. The 
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samples were digested with trypsin; the peptides were analyzed by Orbitrap mass 
spectrometry, and identified using the Max Quant software. Peptide finger printing was 
performed by Dr. Nagarjuna Nagaraj, PhD (MPI Biochemistry Core Facility). The total 
mass spectrometry was used to assess the molecular mass of a protein in solution. ESI-
TOF MS was performed by Elisabeth Weyher-Stingl (MPI Biochemistry Core Facility). 
6.2.11 Edman sequencing 
SDS-PAGE gel with a sample of Sen1976-1880 was blotted onto PVDF membrane. The 
membrane was stained with Amido Black. N-terminal Sequencing of the first four residues 
was carried out by Dr. Josef Kellermann (MPI Microchemistry Core Facility)  
6.2.12 ATP hydrolysis assay 
ATPase assays were performed with 5 nM Sen1 proteins at 28°C in 10-µL reactions 
containing 10 mM Tris–HCl pH 7.5, 75 mM NaCl, 1 mM MgCl2, 1 mM DTT, 25% 
glycerol, and 50 ng/µL polyU. The reaction started with the addition of a 250 µM ATP 
solution containing 0.25 µM of 800 Ci/mmol a 32P-ATP (final concentrations). Aliquots 
were taken at various times, mixed with one volume of quench buffer (10 mM EDTA, 
0.5% SDS), and subjected to thin-layer chromatography on PEI cellulose plates (Merck) 
in 0.35 M potassium phosphate (pH 7.5). Hydrolysis products were analyzed by phosphor-
imaging with Typhoon scanner (Fuji). 
6.2.13 Fluorescence anisotropy  
Fluorescence anisotropy measurements were performed by Dr. Claire Basquin, MPI 
Biochemistry. The 5’-end fluorescein-labeled 15-mer RNA was dissolved to a 
concentration of 10 nM and incubated with Sen1Hel variants at different concentrations 
in a buffer containing 20 mM Hepes pH 7.5, 300 mM NaCl, 2 mM MgCl2, and 1 mM 
DTT. The excitation and emission wavelengths (485 nm and 535 nm, respectively) were 
measured at 20°C in 50-µL reactions on Infinite M1000 Pro (Tecan). Each titration point 
was measured three times using ten reads. The data were analyzed by nonlinear regression 
fitting using the BIOEQS software (Royer, 1993).  
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6.2.14 RNase protection assay 
Proteins (10 pmol each) were mixed with 5 pmol 
32
P body-labeled RNA (kindly provided 
by Fabien Bonneau) to a final 20 µL reaction volume in 50 mM HEPES pH 6.5, 150 mM 
NaCl, 1 mM magnesium diacetate, 10% (v/v) glycerol, 0.1% (w/v) NP-40, and 1 mM 
DTT. After incubation at 4°C for 1 h, the reaction mixtures were digested with 1 µg 
RNase A/T1 mix and 2.5 U RNase T1 (Fermentas) at 20°C for 20 min. Protected RNA 
fragments were then extracted twice with 400 µL phenol:chloroform:isoamyl alcohol 
(25:24:1 (v/v), Invitrogen),  precipitated with 1 mL 100% ethanol. The RNA pellet was 
dried out in speed-vac at 45°C for 10min and then resuspended in 10 µL 10% bromphenol 
blue buffer. The samples were subjected to 22% (w/v) denaturing PAGE (4 M urea), and 
gels were visualized by phosphor-imaging (Fuji). 
6.2.15 In vitro transcription termination assay 
The termination assays were performed by Dr. Zhong Han (Institut Jacque Monod in 
Paris) as described in (Porrua & Libri, 2015a) (Figure 6-5). A ternary Pol II elongation 
complexes were assembled in a promoter-independent manner by incubating the 
RNA:DNA hybrid with purified RNA Pol II. Next, the non-template DNA strand and 
recombinant Rpb4/7 heterodimer were sequentially added to the mixture to form a 
artificial transcription bubble and complete elongation complex. Used RNA is FAM 
labeled and DNA is biotin labeled at the 5’-ends. The ternary Pol II elongation complexes 
were then immobilized on streptavidin beads (Dynabeads MyOne Streptavidin T1 from 
Invitrogen) and washed with transcription buffer (TB) containing 20 mM Tris–HCl pH 
7.5, 100 mM NaCl, 8 mM MgCl2, 10 µM ZnCl2, 10% glycerol, and 2 mM DTT. The 
experiment reactions were performed at 28°C in TB in a final volume of 20 µL in the 
absence or in the presence of 20–80 nM of Sen1 proteins. Transcription was initiated after 
addition of a 1 mM mixture of ATP, UTP, and CTP to allow transcription through the 
G-less cassette up to a G-stretch in the non-template strand. After 15 min the reactions 
were stopped with 1 µL of 0.5 M EDTA and the supernatant was separated from the 
beads. The beads fractions were resuspended in 8 µL of loading buffer (1× Tris-borate-
EDTA, 8 M urea) and boiled for 5 min at 95°C, while RNAs in the supernatant fractions 
were ethanol precipitated and resuspended in 8 µL of loading buffer. Transcripts were 
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subjected to 10% (w/v) denaturing PAGE (8 M urea), and gels were scanned with a 
Typhoon scanner (Fuji).  
 
 
Figure 6-5. Schematic representation of in vitro transcription termination assay 
The ternary Pol II elongation complex contains a biotinylated DNA that has a G-rich site to pause 
the transcription in the absence of GTP in the reaction. Biotinylated DNA allows immobilizing 
the complex on the streptavidin beads. If the helicase Sen1 is added to the reaction, it dissociates 
the elongation complex and the 5’-end FAM labeled transcripts are found in supernatant fraction. 
The transcription termination efficiency is calculated as percentage of released. FAM labeled RNA 
is shown in a dark red bar line and the Pol II shown in a rectangular box. 
 
6.2.16 RNA:DNA duplex unwinding assay 
Duplex unwinding assays were performed by Dr Zhong Han (Institut Jacque Monod in 
Paris). The RNA:DNA annealed using 44-mer RNA oligonucleotide with a 20-mer DNA 
to form a 5’-overhang of RNA. The unwinding reactions were mixed to a final 20 µL 
volume in 10 mM Tris–HCl pH 7.5, 50 mM NaCl, 7.5 µM ZnCl2, 0.5 mM DTT, 10% 
(w/v) glycerol, and 0.1 mg/ml BSA at 28°C. Sen1 proteins were preincubated with the 
corresponding duplex substrate, and the reaction was initiated by adding a 2 mM ATP, 2 
mM MgCl2, and 0.1 µM of unlabeled DNA oligonucleotide to trap the unwound RNA. 
Aliquots were taken at the indicated time-points and mixed with 1 volume of stop/loading 
buffer containing 50 mM EDTA, 1% (w/v) SDS, and 20% (w/v) glycerol. Samples were 
subjected to electrophoresis on a 15% (w/v) native PAGE, and gels were directly scanned 
using Typhoon scanner (Fuji).  
 
+Sen1 
GGGG GGGG 
Beads 
Supernatant 
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6.3 X-ray crystallography 
6.3.1 Protein crystallization 
Purified Sen1Hel was diluted to 3-4 mg/mL (30-35 µM) concentration in SEC buffer 
containing 20 mM HEPES pH 7.5, 300 mM NaCl, 2 mM MgCl2, and 0.5 mM TCEP. 
Protein was then mixed with a 10-fold molar excess of freshly prepared ATP analogues 
and a 1.2 molar excess of RNA. Initial screening was carried out using both commercially 
available screens and in-house screens. The 100 - 500 nL drops were set up 96-well plates 
by mixing to a 1:1 volume ration of protein and crystallization solution using a Phoenix 
pipetting robot. The plates were stored in the incubators at 4°C, 10°C, or 18°C. The 
crystal grow was monitored using an XtalFocus robot (ExploraNova, La Rochelle, France) 
or under a microscope. Once a crystallization hit was observed, the grid screening of initial 
precipitant solution (salt, pH, PEGs, additives) was pursued. The Crystallization facility of 
the MPI Biochemistry carried all automated screenings and drop visualization. 
The best crystals were obtained at 4°C by hanging-drop vapor diffusion from 2-µL drops 
formed by equal volumes of protein and of crystallization solution (6% (w/v) PEG 8000, 
8% (v/v) ethylene glycol, 0.1 M HEPES pH 7.5). The drops formed a film on a surface 
and many of the crystals were attached to it, hence for crystal mounting the drops had to 
be opened on the side and the crystals were scooped with a cryo loop (Hampton Research), 
equilibrated in a range of cryoprotectants and flash frozen in liquid nitrogen. Screening on 
the in-house D8 VENTURE (Bruker) crystallography system showed 25-28% (w/v) 
ethylene glycol to be the most effective cryoprotectant. 
6.3.2 Data collection 
All diffraction data was collected at the super-bending magnet beamline X06DA (PXIII) 
at the Swiss Light Source (Villigen, Switzerland). Native data was collected at 1.0 Å 
wavelength using 0.1° oscillations, exposure time of 0.1sec/frame.  
The S-SAD data collection was performed at 2.095 Å as a compromise to maximize the 
anomalous signal while minimizing absorption. However, collecting many low-dose data 
sets (<0.5 MGy per 360°) from a single crystal and merging the data sets leads to the 
enhanced anomalous signal-to-noise ratio. The beamline is set up with a multi-axis 
goniometer PRIGo, which has an inversed head that is mounted on an air-bearing stage 
and can rotate with a high precision at two angles (χ and ϕ) (Waltersperger et al, 2015). By 
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collecting data in different orientations the systematic errors are reduced as the same 
reflections are measured in different diffraction geometries on different areas of the 
detector. Multi-orientation data collection was carried out on a single crystal. The 4 x 360° 
ω scans were collected at 5° χ increments from 0 to 15° while keeping the ϕ orientation 
constant, using 0.1° ω oscillations, 0.1sec/frame exposure and using a noise-free pixel-array 
PILATUS 2M-F detector (Henrich et al, 2009) at a sample-to-detector distance of 120 
mm.  
6.3.3 Data processing and structure solution 
The data was processed using XDS and scaled and merged with XSCALE (Kabsch, 2010). 
The high-resolution data cutoff was based on the statistical indicators CC1/2 and CC* 
(Karplus & Diederichs, 2012). Substructure determination and phasing were performed 
with SHELXC/D/E (Sheldrick, 2010) using the HKL2MAP interface (Pape & 
Schneider, 2004). The successful SHELXD substructure solution, in a search for 25 sulfur 
sites, had a CCall and a CCweak of 36.9 and 18.2, respectively. Density modification 
resulted in a clear separation of hands. Three cycles of chain tracing resulted in the 
automatic building of 275 amino acids with SHELXE.  
6.3.4 Model building and refinement 
An initial model was built automatically with BUCCANEER (Cowtan, 2006) and 
completed with iterative rounds of manual in the experimental electron density in COOT 
(Emsley & Cowtan, 2004) and refinement against the native data with PHENIX.refine 
(Adams et al, 2010). The model was validated using PHENIX or in wwPDB online tools. 
Figures were generated with PyMOL (Schrödinger). Structural superpositions were 
performed with the structure matching function of COOT or alignment function of 
PyMOL.  
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Appendix  
 
 
Appendix 1. PSIPRED secondary structure prediction of S. cerevisiae Sen1. 
Because of too large protein size, the secondary structure prediction was done in portions: the N-
terminal domain (1-975), the helicase domain (976-1904), and the C-terminal domain (1905-
2231).  
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Appendix 2. All currently available structures of Upf1-like helicases. 
The helicases are colored the same according their domains. The CH-domain of Upf1 is shown in 
light grey and Upf2 is shown in light purple. PDB codes (left to right): 5MZN, 2XZO and 2XZL 
(top), 4B3F, 4B3G, 2XZO and 2WJV (bottom). 
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Appendix 3. List of Sen1 variants. 
Asterisk (*) marks mutations that were introduced to Sen1Hel construct. The constructs that did not 
expressed are marked in red; insoluble – in orange; light green and green indicate low and good 
expression levels, respectively. The helicase activity is scaled from inactive (-) to enhanced activity 
(++++) according to wild-type Sen1Hel. 
Te
st-
exp
res
sio
ns
  Sen1 variants Expression
  1-2231 ✗
  28-937 ✓
  28-983 ✓
  28-1859 ✗
  28-1877 ✗
  28-1880 ✗
  43-1880 ✗
  43-937 ✗
  43-983 ✓
  43-1859 ✗
  43-1877 ✗
RNA binding ATPase Unwinding Termination
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  1095-1859 ✓
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  976-1880 ✓
  1055-1880 ✓
  1084-1880 ✗
  1095-1880 ✓
  1095-1910 ✓
  1105-1904 ✓
  1095-1904  (=Sen1Hel): ✓
  1148-1904 ✗
  1135-1904 ✗
  1128-1904 ✗
 1148-1904,W1166S, L1669N ✗
  *L1121R ✗
  *L1121R, W1132R ✗
  *Y1117R ✗
  *Y1117R, L1121R ✗
  *Y1117R, L1121R, W1132R ✗
  *Δ1470-GSGS-1539 (=ΔUP) ✓
  *Δ1460-SGG-1555  (=ΔLP) ✓
  *ΔUP, L1549D ✓
  *L1549D ✓
  *K1246E ✓
  *R1248E ✓
  *R1263E ✓
  *R1188D, Y1195F ✓
  *Δ1381-GG-1403 ✓
  *Δ1443-GGG-1452 ✓
  *Δ1426-GGG-1439 ✓
  *E1591Q ✓
  *R1820Q ✓
  *T1779P ✓
  *T1779P, R1813A ✓
  *P1622L ✓
  *N1413S ✓
  *N1413S, T1568A ✓
  *T1289A, R1293A ✓
  *D1616V ✗
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